Biological and Therapeutic Implications of α-Synuclein Interactive Molecules and Their Application in Sensor Development by 양지은
 
 
저 시-비 리- 경 지 2.0 한민  
는 아래  조건  르는 경 에 한하여 게 
l  저 물  복제, 포, 전송, 전시, 공연  송할 수 습니다.  
다 과 같  조건  라야 합니다: 
l 하는,  저 물  나 포  경 ,  저 물에 적 된 허락조건
 명확하게 나타내어야 합니다.  
l 저 터  허가를 면 러한 조건들  적 되지 않습니다.  
저 에 른  리는  내 에 하여 향  지 않습니다. 




저 시. 하는 원저 를 시하여야 합니다. 
비 리. 하는  저 물  리 목적  할 수 없습니다. 
경 지. 하는  저 물  개 , 형 또는 가공할 수 없습니다. 
공학박사 학위논문 
 
Biological and Therapeutic Implications of  
-Synuclein Interactive Molecules and Their 
Application in Sensor Development  
 
알파-시뉴클린 상호작용성 분자들의 생물학적 














Biological and Therapeutic 
Implications of -Synuclein Interactive 
Molecules and Their Application in 
Sensor Development  
 
Jee Eun Yang 
School of Chemical and Biological Engineering  
The Graduate School  
Seoul National University 
 
-Synuclein, amyloidogenic protein, is a major component of Lewy bodies 
which are commonly observed in Parkinson’s disease patients. Oligomeric 
intermediates which are observed during amyloidogenesis of this protein are 
assembled into various fibrillar structures via specific pathway called unit 
assembly. These amyloid fibrils have different physicochemical properties 
corresponding to amyloid polymorphism. Furthermore, unit assembly of -
synuclein oligomers on the surface of liposome induces the formation of 
radiating amyloid fibrils, resulting disruption of lipid membrane structure. 
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Therefore, it can be considered that unit assembly of oligomers on the lipid 
membrane is the cause of -synuclein-mediated cellular degeneration in a 
molecular level. 
 In this study, -synuclein interactive molecules have been 
investigated in order to control the oligomer-mediated cytotoxicity. First of 
all, mutual effect of -synuclein and protein partners such as firefly luciferase 
(LUC) and glutathione peroxidase-1 (GPX-1) are investigated to unveil their 
involvement in the PD pathogenesis in terms of fibrillar polymorphism and 
cellular antioxidant defense mechanism. First of all, LUC and GPX-1 bind to 
-synuclein with Kd of 8.1 M and 17.3 nM, respectively and they are shown 
to accelerate the fibrillation and induce amyloid polymorphism of -
synuclein by acting as a novel template. In case of LUC-directed amyloid 
fibrils, altered morphological characteristics were inherited to next-
generations via nucleation-dependent fibrillation process. The seed control, 
therefore, would be an effective means to modify amyloid fibrils with 
different biochemical characteristics. In addition, the LUC-directed amyloid 
fibrillar polymorphism also suggests that other cellular biomolecules are able 
to diversify amyloid fibrils, which could be self-propagated with diversified 
biological activities, if any, inside cells. Mutual interactions of -synuclein 
and GPX-1 contributed to not only accelerated -synuclein fibrillation but 
also enhancement of GPX-1 activity. Furthermore, the entrapped GPX-1 in 
the fibrillar meshwork of -synuclein was protected in a latent form and its 
activity was fully recovered as released from the matrix. Therefore, novel 
defensive roles of -synuclein and its amyloid fibrils against oxidative stress 
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are suggested as the GPX-1 stimulator and the active depot for the enzyme, 
respectively. 
 In this study, several phenolic compounds are examined to control 
the effects of oligomeric species on cellular membrane and cell viability. First 
of all, specific oligomer which is -sheet free, can be assembled into curly 
amyloid fibril (CAF) through repetitive membrane filtration and instantly 
transform into radiating amyloid fibril (RAF) on phosphatidylcholine 
liposome is defined as active oligomer. The changes of tyrosine intrinsic 
fluorescence of -synuclein have shown that phenolic compounds such as 
resveratrol (RSV), curcumin (CUR) and (-)-epigallocatechin gallate (EGCG) 
directly interact with -synuclein with Kd of 30.4 mM, 133 mM and 100 mM, 
respectively. According to the Coomassie Brilliant Blue-stained SDS-PAGE 
and CD spectroscopy, phenolic compounds have significant influences on the 
fibrillation of -synuclein by either facilitating the formation of compact 
oligomers or accelerating the formation of amyloid fibrils with high -sheet 
contents. Furthermore, phenolic compounds could effectively control the 
formation of CAF and RAF and then reduce the cytotoxicity of active 
oligomer.  
 Robust polydiacetylene-based colorimetric sensing material has been 
developed with amyloid fibrils of -synuclein in the presence of 10,12-
pentacosadiynoic acid (PCDA) by taking advantage of specific fatty acid 
interaction of -synuclein and structural regularity of the self-assembled 
product of amyloid fibrils. PCDA facilitated not only self-oligomerization of 
-synuclein but also its fibrillation into the fibrils with increased thickness. 
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Upon UV irradiation, the PCDA-containing amyloid fibrils (AF/PCDA) 
turned to blue, which then became red following heat treatment. The blue-to-
red color transition was also observed with other stimuli of pH and ethanol. 
AF/PCDA were demonstrated to be mechanically stable since not only the 
individual colors of blue and red but also their colorimetric transition were 
not affected by a number of sonications which readily disrupted the 
polydiacetylene (PDA) vesicles with instant loss of the colors. Therefore, 
AF/PCDA can be considered as a novel PDA-based colorimetric sensing 
material with high mechanical strength, which has potential to be employed 
in various areas involving advanced sensing technologies. Furthermore, 
litmus-type sensors capable of detecting temperature and organic solvents 
have been developed with -synuclein amyloid fibrils and PCDA. The PCDA 
molecules localized on the amyloid fibrils through either co-incubation with 
monomeric -synuclein (AF/PCDA) or simple mixing with the pre-made -
synuclein amyloid fibrils (AF+PCDA) were photopolymerized with UV to 
exhibit blue color on paper. The paper sensors prepared with AF/PCDA and 
AF+PCDA showed distinctive sensitivities toward temperature and solvents. 
The less tight binding of PCDA to amyloid fibrils and thus increased its 
molecular freedom would be responsible for the discrete sensing property. In 
addition, the AF+PCDA sensor was demonstrated to successfully follow 
ascending temperature change, which could allow the litmus-type sensor to 
monitor thermal history of materials. Taken together, the amyloid fibrils of 
-synuclein are shown to be a decent template for PCDA to develop into the 
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Part I. Biological and Therapeutic Implications of   






Amyloidogenesis is the formation of insoluble protein nanofibrils known as 
amyloid (Figure 1) through misfolding and abnormal assembly of soluble and 
innocuous proteins under pathological conditions such as oxidative stress and 
genetic mutation [1]. Amyloids are typically long and fibrous structure, 5-15 
nm in width and several micrometers in length [2, 3] and characterized by a 
cross -sheet structure with the hydrogen bonded amino acids aligned 
perpendicular to the fibrillar axis. When the structure of amyloids is 
investigated by X-ray diffraction, there are simple patterns with longitudinal 
diffraction line at 4.7 Å  and transverse diffraction line at 10 Å . They are 
characteristic of a cross- structure [4-6].  
Abnormal aggregation into amyloid fibrils has significant 
implication in the pathogenesis of neurodegenerative diseases even though 
the cause-and-effect relationship between amyloidogenesis and onset of 
diseases remain largely unknown [7]. Amyloid plaques caused by abnormal 
accumulation of insoluble protein fibrils have been observed in various 










Figure 1. The structure of amyloid. (A) X-ray diffraction of amyloid protofilament. 
(B) The cross- structural core of amyloid protofilament. (C) The protofilaments self-
associated to from the mature amyloid fibril. [Serpell. Essays Biochem. 56 (2014) 1-
10] (D) Transmission electron spectroscopy image of amyloid fibril. Scale bar 





Dementia with Lewy bodies, Creutzfeldt-Jakob disease, Huntington’s disease 
and Amyotrophic lateral sclerosis. (Table 1).  
 
2. Parkinson’s disease and -synuclein 
 
Parkinson’s disease, the second most common neurodegenerative disease, is 
characterized by neuronal loss and neuronal Lewy bodies in the substantia 
nigra. The most obvious symptoms are related with movement including 
tremor, rigidity, slowness of movement and difficulty with walking. Previous 
studies have shown that -synuclein may be closely connected with PD 
because this protein is the major component of Lewy bodies in 
histopathological sections of PD patients (Figure 2) [8].  
In particular, it has been investigated that several environmental risk 
factors contribute to the development of sporadic PD [9-11] and affect 
abnormal assembly of -synuclein molecules. For example, exposure to 
lipophilic pesticide, rotenone, causes the degeneration of dopamine neurons 
that is associated with movement trouble such as rigidity [12]. Furthermore, 
high blood levels of heavy metals such as manganese, copper and iron are 
commonly observed in PD patients [13, 14]. The conformational change and 
significant acceleration of -synuclein fibrillation are observed in vitro in the 
presence of pesticides such as rotenone, dieldrin and paraquat [15] and di- 
and trivalent metal ions, especially copper (II), iron, cobalt, and manganese 
[16]. Therefore, it can be considered that these environmental toxins are 

























































































molecules, inducing -synuclein dysfuction that is toxic to the dopaminergic 
neurons [17]. On the other hand, the familial PD is rarely developed due to 
mutation in specific genes such as SNCA, LRRK2, and PINK1. Especially, 
three missense mutations in SNCA, which are A30P, E46K and A53T, have 
been observed in Lewy bodies of PD patients [18–20] and overexpression of 
wild type -synuclein due to gene triplication have also reported to lead to 
the development of PD [21, 22].  
 
3. Mechanism of amyloidogenesis  
 
According to the previous studies, multiple assembly pathways lead to 
various types of amyloid fibrils with distinct morphologies [23-25]. For 
example, 2-microglobulin of amyloidogenic protein are assembled into 
worm-like fibrils or rod-like fibrils according to experimental conditions such 
as pH and the concentration of salts [26]. From these studies, it can be 
considered that amyloidogenesis occurs via multiple mechanisms.  
Mechanisms of amyloidogenesis are classified into template-
dependent and template-independent fibrillation according to whether the 
protein assembly depends on pre-existing template [27]. First of all, in 
template-dependent fibrillation, the conformation of unfolded monomeric 
proteins may be converted to the amyloidogenic form in the presence of pre-
existing template (Figure 3) [28, 29]. The nucleation-dependent fibrillation 
model reflecting template-dependent fibrillation has been widely accepted as 







Figure 3. Template-dependent fibrillation. (A) Monomers acting as active growing 
unit are converted to the amyloidogenic form upon binding to pre-existing template. 
(B) Monomers acting as passive growing unit selectively binds to pre-existing 
template, inducing equilibrium shift of conformer. (C) Kinetics of amyloidogenesis. 




fibrillation, monomeric proteins are assembled into amyloid fibrils through 
three stages including lag, exponential, and stationary phase (Figure 3C). 
Once nucleus forms during the lag phase, the monomers adhere to the nucleus, 
experience the conformational transition into amyloidogenic form and then 
grow into the fibrillar structures (Figure 3D) [32]. On the other hand, in 
template-independent fibrillation, the amyloidogenic conformations may be 
induced in the absence of template prior to the molecular assembly process. 
A specific conformer among the various conformers in a state of equilibrium 
is amyloidogenic and self-associative and then turn into final fibrils by 
shifting equilibrium (Figure 4) [27]. Occasionally, the formation of the self-
associative conformer is facilitated by a specific ligand such as a cyclic 
tetrapyrrole compound [33] and metal irons [34, 35], and then fibrillation can 
be further accelerated. Recently, a novel amyloidogenesis model of -
synuclein named unit-assembly has been reported and this model reflects the 
template-independent fibrillation. Based on this unit-assembly model, 
oligomeric species generated through association of -synuclein monomers 
act as a growing unit for the fibril formation in the absence of template (Figure 
5). Also, since oligomeric species are thermodynamically pseudo-stable, their 
conformations are prone to be distorted in the presence of chemical and 
physical influences, resulting amyloid polymorphisms [36, 37].  
 
4. -Synuclein, an intrinsically unstructured protein (IUP)  
 










Figure 4. Template-independent fibrillation. (A) Ligand-induced fibrillation. (B) 





























intrinsically unstructured and acidic protein with molecular weight  of 14 kDa. 
The protein has three distinctive domains in its primary structure including 
amphipathic N-terminal region (residues 1-60), central hydrophobic region 
(residues 61-95), and highly acidic C-terminal region (residues 96-140) 
(Figure 6). The N-terminus which consists of four 11-amino acid imperfect 
repeats (KTKEGV) is related with -helical structure formation in vitro and 
membrane binding by interacting with acidic phospholipids [38, 39]. The 
central hydrophobic region which includes amyloidogenic NAC (non-
amyloid- component) region is essential for protein aggregation by forming 
a core region of the fibrils of -synuclein [40]. The C-terminus with abundant 
acidic amino acids and proline residues contains several sites of ligand 
binding such as dopamine and its derivatives [41] and metal ions binding such 
as Ca(II) [42] and Cu(II) [43, 44] ions.  
Although it is generally accepted that folded protein structure is 
necessary for biological function, not all functional proteins are intrinsically 
structured and folded into stable globular structure. Unstructured regions of 
significant size have been commonly observed in functional proteins under 
native conditions by using X-ray crystallography, NMR spectroscopy, CD 
spectroscopy and protease sensitivity. The flexible structures of proteins 
containing unstructured regions are involved in molecular recognition. 
Therefore, intrinsic disorder of proteins plays numerous roles in binding to 
their substrate, ligand, other proteins, nucleic acid polymers, lipid, heme and 
metal ions [45-47]. Interestingly, protein disorder databases, DisProt [48] and 












Figure 6. -Synuclein. (A) Amino acids sequence of -synuclein. (B) The three 







contain one or more of amyloidogenic region. Also, decrease of unstructured 
region is correlated with decrease of amyloidogenic region content in protein 
sequence [50]. According to the protein disorder database, a typical 
amyloidogenic protein, -synuclein, is a highly intrinsically unstructured 
protein and its functions include protein binding [51], polymerization and 
metal binding [52]. In fact, it has been reported that -synuclein interacts with 
various chemicals and biomolecules including Cu(II) [43, 44], Coomassie 
Brilliant Blue [53], oxidized glutathione [54], lipid [55], phthalocyanine 
tetrasulfonates [56], dequalinium [57], eosin [58], luciferase [59, 60], and 
glutathione peroxidase [61]. Taken together, it can be considered that there 
are a lot of unknown -synuclein interactive molecules and they may affect 
biological and pathological functions of -synuclein.  
 
5. Neurotoxicity of -synuclein oligomers 
 
Many researchers have demonstrated that oligomeric intermediates are the 
most neurotoxic species [62, 63]. It has been demonstrated that -synuclein 
oligomers can disrupt synthetic lipid vesicles [64, 65] and lead to cell death 
in vitro [66, 67] and in animal models [68, 69]. These effects of -synuclein 
oligomers on membrane disruption and permeability have been explained by 
two mechanisms. First of all, annular oligomers may integrate into membrane 
and form pores or channel-like structures leading to membrane permeability 
[70-72]. Otherwise, -synuclein oligomers may facilitate the movement of 
ions across the membrane bilayer without the formation of pores [73].  
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 Intermediates which are observed in the early stage of fibrillation are 
called oligomers and structure and property of these species are highly diverse. 
For example, it has been reported that -sheet rich oligomers of -synuclein 
are spherical and show the polydispersed size distribution from 10 nm to 60 
nm [74]. Also, smaller spheroidal oligomers with 1.5 - 3.2 nm in height were 
characterized by primarily -helical structure [75]. The wreath-shaped -
synuclein oligomers with diameter of 18 nm was identified by using small 
angle X-ray scattering [76]. Furthermore, oligomeric species can recognize 
environmental changes resulting conformational change and acceleration of 
fibrillation. For example, subtle conformational distortions were caused by 
exposure to temperature varying from 37°C to 43°C, which consequently led 
to fibrillar polymorphism [77]. Also, when -synuclein oligomers were 
incubated with small amount of organic solvent, nanofibrils were instantly 
generated through unit assembly [78]. Taken together, it can be considered 
that thermodynamically unstable oligomeric species are attractive therapeutic 
targets because oligomers may be easily altered into stable and less toxic 
structure. 
 
6. -Synuclein interactive molecules  
 
As mentioned previously, -synuclein has potential for interacting with 
multiple ligands such as lipids, metal ions, proteins and small chemicals 
because it is intrinsically unfolded protein. In this study, self-assembly of -
synuclein is modulated by interacting with other protein molecules such as 
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firefly luciferase and glutathione peroxidase-1 and small molecules from 
natural phenolic compounds.  
 
6-1. Firefly luciferase 
Firefly luciferase (LUC) has been widely used in molecular and cell biology 
for the detection of ATP and as a reporter to study gene expression [79, 80]. 
Firefly luciferase (LUC) is an oxidative enzyme that catalyzes generation of 
yellow-green light from chemicals of luciferin and ATP (Figure 7A). 
Furthermore, firefly luciferase which is a bifunctional enzyme also has 
catalytic function of fatty acyl-CoA synthesis (Figure 7B).  
 
6-2. Glutathione peroxidase  
Selenium-containing glutathione peroxidases (GPXs) are important 
antioxidant enzymes protecting the organism from oxidative damages by 
removing hydrogen peroxide and various organic peroxides. GPX primarily 
catalyzes the reaction of converting hydrogen peroxide to water by oxidizing 
reduced glutathione (GSH) to glutathione disulfide (GSSG) in cytoplasm. 
Glutathione reductase then reduces the oxidized glutathione to complete the 
cycle (Figure 8A) [81]. GPX-1 of several isozymes is the most abundant 
enzyme found in the cytoplasm of nearly all mammalian tissues. Because of 
its crucial role resistant to oxidative stress, GPX-1 has been implicated in 
development  and prevent ion of many diseases including cancer, 
neurodegenerative diseases, and cardiovascular disease [82, 83]. According 











Figure 7. Reactions catalyzed by firefly luciferase. (A) Bioluminescence reaction. 













Figure 8. Antioxidant enzyme system and -synuclein. (A) Glutathione 
peroxidase reaction. (B) Confocal localization of -synuclein (red) and glutathione 
peroxidase (green) in Lewy bodies. Scale bar represents 5 m. [John et al. Acta. 







synuclein in Lewy bodies in the brain tissues of PD patients, suggesting a 
neuroprotective role of GPX-1 toward the disease (Figure 8B) [84]. Since 
molecular-level inter-relationship between the two co-localized proteins is 
basically unknown, their mutual effects have been investigated in this study 
by assessing the accelerated fibrillation of -synuclein by GPX-1 and the 
stimulated GPX-1 activity by -synuclein.  
 
6-3. Natural phenolic compounds 
Natural phenolic compounds are abundant in fruits, vegetable and herbal 
beverage such as berries, tumeric, soybeans, green tea and red wine. [85] 
They constitute a large number of phytochemicals with more than 8000 
compounds (Figure 9). According to previous studies, phenolic compounds 
have various physiological properties such as anti-oxidant [86, 87], anti-
microbial [88], anti-inflammatory [89] and cardioprotective [90] effects. In 
particular, protection of plants against reactive oxygen species (ROS) is the 
most attractive function of phenolic compounds and have been primarily 
studied. Furthermore, it has been reported that several phenolic compounds 
such as resveratrol [91] and (-)-epigallocatechin gallate (EGCG) [92, 93] 
show effects of protection against aging and related neurodegenerative 
disease [94]. First of all, resveratrol can protect cells against oxidative stresses 
by reducing generation of ROS [95], scavenging free radicals [96] and 
preventing accumulation of ROS [97]. Also, studies on neuroprotective 
effects of curcumin have been showed that curcumin treatment reduces 








































(GSH) level [99]. It has been revealed that EGCG among different 
polyphenols is the most effective radical scavenger [100, 101] and long-term 
treatment with EGCG resulted increase in lifespan and movement 
improvement in a Drosophila melanogaster model of Parkinson’s disease 
[93]. To summarize various studies, neuroprotective effects of phenolic 
compounds may be resulted from anti-oxidant and anti-amyloidogenic 
properties, modulation of neural mediators and enzymes, interaction with 
signaling pathways, and inhibition of NMDA neurotoxicity [102].  
 
II. Experimental Section 
 
1. Purification of -synuclein 
 
Human recombinant -synuclein cloned in pRK172 was expressed in 
Escherichia coli BL21 (DE3) and purified according to the procedure 
described previously [103]. In order to make starter culture for protein 
expression, a colony of cells transformed with human recombinant - 
synuclein plasmid was picked up from LB agar plate and put in 100 mL of 
LB medium containing 0.1 mg/mL ampicillin. The cells in LB medium were 
incubated for about 7 hours at 37°C in orbital shaker at 200 rpm. 1 mL of 
starter culture was added into 1 L of LB medium with ampicillin and cultured 
at 37°C in orbital shaker until the optical density at 600 nm was about 0.6. 
Then the culture was induced by adding 0.5 mM of isopropylthiogalactoside 





Figure 10. Purification of -synuclein. (A) DEAE-sephacel anion exchange 
chromatography. (B) S-sephacryl S-200 size exclusion chromatography. (C) S-




by centrifugation and the cell pellet was lysed with freezing-thawing method 
and lysis buffer containing 0.1 M NaCl, 0.1 mM PMSF, 1 g/mL Leupeptin, 
2 mM EDTA, 0.1 mg/mL lysozyme, and 10 units/mL DNase in 20 mM Tris-
HCl (pH 7.5). After cell lysis, the cell debris was removed by centrifugation 
and the supernatant was boiled at 100°C for 20 min and cooled down in ice. 
After the cell lysate was filtered through a syringe-driven filter with a pore 
size of 0.21 m, the lysate was purified with three chromatography steps 
including anion exchange (DEAE Sephacel), size-exclusion (S-200), and 
cation exchange (S-Sepharose) chromatography (Figure 10). Following 
dialysis against 6 L of 20 mM Mes (pH 6.5), the completely purified - 
synuclein was stored in aliquots at –80°C. 
 
2. Firefly luciferase assay 
 
Assay mixture was made up with 1 mM ATP, 2 mM MgSO4, and 188 M 
luciferin in 25 mM Tricine (pH 7.8). Bioluminescence of the Luciferase 
activity was monitored with chemiluminescence spectrophotometer (LS-55B, 
Perkin-Elmer). Light emission was measured at 550 nm with an integration 
time of 0.02 sec.  
 
3. Thioflavin-T binding fluorescence assay 
 
-Synuclein (0.5 mg/mL) was incubated in 20 mM Mes (2-(N-morpholino) 
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ethanesulfonic acid, pH 6.5) at 37°C under a shaking condition at 200 rpm. 
During the incubation, -synuclein was mixed with 2.5 mM Th-T in 50 mM 
glycine (pH 8.5) at room temperature. The fluorescence was monitored with 
chemiluminescence spectrophotometer (LS-55B, Perkin-Elmer). The 
resulting fibrillar formation of -synuclein was estimated with Th-T binding 
Th-T binding fluorescence at 485 nm with an excitation at 450 nm. 
 
4. JC-1 binding fluorescence assay 
 
-Synuclein and its amyloid fibrils were incubated with 1.2 M JC-1 in 20 
mM Mes (pH 6.5) containing 5% DMSO. The 5,5',6,6'-Tetrachloro-1,1,3,3'-
tetraethylbenzimidazolyl carbocyanineiodide (JC-1) binding fluorescence 
spectra were obtained between 500 and 600 nm with an excitation at 490 nm. 
The JC-1 fluorescence was measured with chemiluminescence 
spectrophotometer (LS-55B, Perkin-Elmer).  
 
5. Quantification of the remaining monomers after fibrillation 
 
After the fibrillation reached a stationary phase, the -synuclein amyloids 
were precipitated with centrifugation at 13200 rpm for 30 min. The amount 
of soluble -synuclein monomers remaining in the supernatant was measured 
with bicinchoninic acid (BCA) protein assay (Thermo Fisher Scientific Inc.). 
 




An aliquot (20 L) of sample was adsorbed onto a carbon-coated copper grid 
(200-mesh, Electron Microscopy Sciences) and dried in the air for 3 min. 
Following negative staining of the air-dried sample with 2% uranyl acetate 
(Electron Microscopy sciences) for 5 min, the grids containing the amyloid 
fibrils were visualized with TEM (JEM1010, JEOL). 
 
7. Attenuated total reflectance-Fourier transformation-infrared (ATR –
FTIR) spectrophotometer 
 
The collected pellets of amyloid fibrils were placed on ZnSe ATR crystal. 
ATR spectra of amyloid fibrils were measured with Nicolet 6700 FTIR 
spectrometer equipped with DTGS detector (Thermo Fisher Scientific Inc.). 
Data fitting and curve deconvolution for the ATR-FTIR spectra were 
performed using OriginPro 8.0 software (OriginLab, Northampton, MA). 
 
8. 8-anilino-1-naphthalenesulfonic acid (ANS) binding fluorescence 
assay 
 
Protein was incubated with 20 M ANS in 20 mM Mes (pH 6.5) at room 
temperature. The ANS binding fluorescence spectra were obtained between 
400 and 600 nm with an excitation at 350 nm. The fluorescence was measured 




9. Self-propagation experiment 
 
Amyloid seeds were prepared with ultrasonication of the mature amyloid 
fibrils using a micro-tip-type ultrasonic processor (VCX 750, Sonics & 
Materials Inc.). Sonication was performed repeatedly for total of 10 cycles 
with the fibrils located on ice. Each cycle consisted of an on/off cycle for 15 
sec each. After each cycle of sonication, the sample was quiescently placed 
on ice for 60 sec. The resulting amyloid fragments were examined with TEM 
and used as the seeds. Daughter fibrils were developed by seeding monomeric 
-synuclein with the amyloid fragments at 5% (w/w). 
 
10. Glutathione peroxidase-1 (GPX-1) assay 
 
GPX-1 activity was measured by a coupling system employing cumene 
hydroperoxide and GSH in the presence of glutathione reductase and NADPH. 
Oxidized glutathione formed by GPX-1 reaction (H2O2 + 2GSH → GSSG + 
2H2O) was continuously reduced by glutathione reductase activity (GSSG + 
NADPH + H+ → 2GSH + NADP+). GPX-1 activity was calculated from the 
decrease in NADPH absorbance at 340 nm. The assay mixture included 0.1 
mM each of cumene hydroperoxide, GSH, and NADPH and 0.1 unit 
glutathione reductase in 50 mM Tris/Cl (pH 7.6) containing 5 mM EDTA. 
Protein samples were lastly added into the assay mixture and the 
measurement was performed immediately. Dissociation constant (Kd) 
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between -synuclein and GPX-1 was evaluated with a double reciprocal plot 
of the hyperbolic enhancement curve. The reciprocals of -synuclein 
concentrations and initial activities of GPX-1 were plotted on the x- and y-
axes, respectively, to obtain Kd from x-intercept.  
 
11. Immunochemical analysis 
 
For immunocytochemistry, neuroblastoma SH-SY5Y cells cultured on the 
coverslips were fixed in ice-cold methanol/acetone solution (1:1) at −20°C 
for 10 min, washed and blocked with a blocking buffer (1% bovine serum 
albumin in phosphate buffered saline) for 30 min at 37°C. The fixed cells 
were incubated in the blocking buffer containing mouse anti--synuclein 
antibody and goat anti-GPX-1 antibody for 2 h, and then incubated with the 
fluorescent secondary antibodies of anti-mouse Alexa Fluor 488 (Thermo 
Fisher Scientific) and rabbit anti-goat Alexa Fluor 633 (Thermo Fisher 
Scientific) for 1 h in the dark. After washing with the blocking buffer, the 
cells were mounted with a mounting medium and examined using a confocal 
microscope (LSM510, Carl Zeiss). For immunogold labeling of the entrapped 
GPX-1 within amyloid fibrils, the sample was adsorbed onto a carbon-coated 
copper grid for 15 min at room temperature. After removing excess liquid 
with a filter paper, the adsorbed sample was incubated successively with goat 
anti-GPX-1 antibody and gold-conjugated anti-goat antibody for 1 h each. 
After washing with 20 mM MES (pH 6.5), the adsorbed sample was 





12. Intrinsic fluorescence of -synuclein 
 
-Synuclein (35 M) was preincubated in the absence and presence of 
various concentrations of phenolic compound for 30 min at 37°C, and the 
intrinsic tyrosine fluorescence of -synuclein was monitored between 300 nm 
and 400 nm with excitation at 274 nm by using a chemiluminescence 
spectrophotometer (LS-55B, PerkinElmer). A saturation curve was obtained 
by plotting the difference in the intrinsic fluorescence obtained in the absence 
(I0) and presence (Ii) of phenolic compounds as a function of phenolic 
compounds concentration. Dissociation constant Kd was obtained from the 
x-intercept of a double-reciprocal plot of the hyperbolic saturation curve 
between 1/[phenolic compounds] and 1/(I0 − Ii) on the x and y axes, 
respectively. 
 
13. Liposome synthesis 
 
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine (DOPC, Avanti 
Polar Lipids Inc.) in a test tube was dissolved with chloroform at 1 mg/mL, 
and followed by blowing N2 gas until chloroform evaporated. Furthermore, 
the tube was stored in desiccator overnight to remove chloroform completely 
and then stored at –20°C. In order to peel the lipid film readily, the tube was 
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heated in a water bath of 80°C for 1 min. And then this film was incubated 
with 1 mL of 20 mM Mes (pH 6.5) at 60°C for 1 hr in orbital shaker (300 rpm) 
to rehydrate lipid film. The suspension was extruded at 60°C using an 
extruder set (Avanti Polar Lipids Inc.) and polycarbonate membrane with a 
pore size of 200 nm. The homogeneous suspension of unilamellar vesicles 
was examined with TEM. 
 
14. Cytotoxicity assay 
 
Human dopaminergic neuroblastoma cells (SH-SY5Y) were incubated in 
Dulbecco’s modified eagle medium (DMEM, GE Healthcare) with 10 % fetal 
bovine serum and 50 unit/mL penicillin/streptomycin in 5% CO2 at 37°C. The 
cells were inoculated in a 96-well plate at ~1.0 x 106 cells/well. After the cell 
confluency reached about 90%, the mixtures of -synuclein oligomers and 
small molecules were added to the cells, and further incubated for 24 hours 
in 5% CO2 at 37°C. The cell proliferation was measured with MTS assay 
which is a colorimetric method for determining the number of viable cells via 
the reduction reaction of MTS tetrazolium compounds into colored formazan 
by active cells (Figure 11) [104]. 20 L of MTS solution was added to culture 
wells and incubated for 4 hours in 5% CO2 at 37°C. In order to stop reaction, 
25 L of 10% SDS was added to each well and then absorbance at 490 nm 
was measured with a 96-well plate reader. 
 
























The size distribution of -synuclein amyloid fibrils incubated with and 
without EGCG was measured using DLS (Zetasizer Nano ZS, Malvern) at 
25°C. Amyloid fibrils isolated with centrifugation were further incubated for 
1 hr at 37°C in orbital shaker with 0 mM, 0.1 mM and 0.3 mM EGCG. After 
incubation, the mixture of amyloid fibrils and EGCG was collected via 
centrifugation at 16100 × g for 30 min and then the collected pellets were 
resuspended with 1 mL of distilled water.  
 
16. Circular dichroism (CD) spectroscopy 
 
Secondary structure of -synuclein aggregates prepared with phenolic 
compounds were evaluated with CD spectroscopy (Chirascan-plus, Applied 
Photophysics). The spectra were obtained between 195 and 260 nm with a 
step resolution of 0.1 nm and scan speed of 10 nm/min by using a 10 mm path 
length quartz cell. In order to estimate the secondary structure, CD spectra 
were analyzed by using the convex constraint algorithm (CCA). 
 
III. Results and Discussion 
 
1. Molecular interaction of -synuclein and firefly luciferase 
contributes to the amyloid polymorphism of -synuclein 
 
-Synuclein which is abundant in the brain has reported to be involved in 
brain lipid metabolism by modulating the activity of acyl-CoA synthetase 
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[105, 106]. Intriguingly, firefly luciferase which is a bifunctional enzyme also 
has catalytic function of acyl-CoA synthesis [Figure 7B] with a genetic 
similarity to acyl-CoA synthetase [107, 108]. It can be expected that activity 
of firefly luciferase is affected by -synuclein, and therefore this study is deal 
with interaction between -synuclein and firefly luciferase.  
 
1-1. -Synuclein enhances the activity of firefly luciferase 
According to the previous study [59], -synuclein enhanced the 
bioluminescent activity of firefly luciferase (LUC), which led to suggest -
synuclein as a novel protein regulator for LUC. The initial bioluminescence 
of LUC increased sharply from 69 to 95 AU in the presence of 7 M -
synuclein (Figure 12A). When activity of LUC was evaluated with - 
synuclein, -synuclein, bovine albumin serum and lysozyme, the 
enhancement of bioluminescence was observed only with -synuclein 
(Figure 12B). The enhanced bioluminescence of LUC exhibited a hyperbolic 
relationship with -synuclein (Figure 12C) and then their dissociation 
constant was estimated as 8.1 M from the x-intercept of a double-reciprocal 
plot of the hyperbolic saturation curve between 1/[-synuclein] and 
1/[bioluminescence] (Figure 12C, inset). Therefore, this study has suggested 
the specific interaction between -synuclein and LUC and enhancement of 
LUC activity. Alternatively, LUC can be expected to have influences on the 





Figure 12. -Synuclein effects the bioluminescence of firefly luciferase. (A) 
Enhancement of bioluminescence by -synuclein. (B) Bioluminescence assay of 
firefly luciferase in the presence of -synuclein, -synuclein, BSA and lysozyme. (C) 
Relative intensities of the bioluminescence in the presence of -synuclein at various 
concentration. The inset shows a double-reciprocal plot of the hyperbolic effect of -





1-2. Firefly luciferase accelerates the fibrillation of -synuclein and 
induces the morphologically distinctive fibrils 
In order to investigate the effect of firefly luciferase (LUC) on the fibrillation 
of -synuclein, kinetics of fibrillation was monitored by thioflavin-T (Th-T) 
binding fluorescence of amyloid fibrils at first. Kinetics study showed that the 
fibrillation of -synuclein was considerably accelerated by LUC (Figure 
13A). The lag phase reduced from 20 hours to 6 hours and the final intensity 
of Th-T binding fluorescence increased by one and a half-fold in the presence 
of LUC at 0.1 M. According to a previous study, JC-1 (5,5’,6,6’-tetrachloro-
1,1,3,3’-tetraethylbenzimidazolyl carbocyanine iodide) can also be used as a 
fluorescent probe to classify -synuclein according to its assembled states 
between the intermediate oligomers and the final fibrils [109]. In the absence 
and presence of LUC, the JC-1 binding fluorescence spectra of amyloid fibrils 
were monitored between 500 nm and 600 nm with an excitation at 490 nm 
(Figure 13B). The JC-1 binding fluorescence of the -synuclein amyloid 
fibrils prepared in the absence of LUC exhibited the maximum at 539 nm, 
which was dramatically increased by 4-fold for the fibrils obtained with LUC. 
In addition, the JC-1 binding fluorescence for the LUC-induced fibrils 
showed another significant shoulder peak at 561 nm, indicating a distinctive 
feature of the fibrils derived with LUC.  
 In order to clarify whether the increases in the final Th-T and JC-1 
















Figure 13. Enhanced amyloid fibril formation with LUC and the fibrillar 
polymorphism of -synuclein in the presence and absence of LUC. (A) 
Fibrillation kinetics of -synuclein (35 M) in the presence (gray) of LUC (0.1 M). 
-Synuclein (black) and LUC (dotted lines) were separately incubated as controls. 
(B) JC-1 binding fluorescence of the -synuclein amyloid fibrils prepared without 
(black) and with LUC (gray). Dotted lines indicate the respective spectra prior to the 
incubation without (black) and with LUC (gray). (C) Amounts of soluble -synuclein 
left in the supernatant before (black) and after (gray) the fibrillation for 70 hours at 
37°C. (D) TEM images of amyloid fibrils obtained in the absence (left) and presence 
(right) of LUC. Magnified (x 4) images are also presented in the insets. Scale bars 
represent 200 nm. (E) FT-IR spectra of the fibrils prepared in the absence (a) and 
presence (b) of LUC at amide I region (1600-1700 cm-1). The gray lines obtained via 
the spectral deconvolution represent protein secondary structures constituting the 






amount of fibrils, the monomer levels left behind following 70 hours of the 
extensive fibrillation in the presence and absence of LUC were monitored 
with bicinchoninic acid (BCA) protein assay (Figure 13C). The data show 
that the remaining monomer levels are little different under both conditions 
with and without LUC, suggesting that LUC presumably yielded a different 
type of amyloid fibrils. Examination with transmission electron microscopy 
(TEM) confirmed the distinctive fibrillar structures between the final fibrils 
obtained in the absence and presence of LUC (Figure 13D). In the presence 
of LUC, the fibrils were thicker than the fibrils prepared with -synuclein 
alone and formed densely populated fibrillar meshwork reflecting more 
associative nature of the LUC-induced fibrils. The fibrils with LUC showed 
an average width of 16 nm while the fibrils without LUC was 8 nm.  
 To elaborate the fibrillar polymorphism, FT-IR spectrophotometer 
was employed to assess the secondary structures of the fibrils (Figure 13E). 
In particular, amide I band (1600-1700 cm-1) has been employed to evaluate 
structural and conformational characteristics of proteins [110-112]. Spectra 
of the -synuclein fibrils produced without (Figure 13E-a) and with (Figure 
13E-b) LUC were deconvoluted at 1619, 1630, 1650, and 1668 cm-1 using 
OriginPro 8.0 program, which represent anti-parallel -sheets, parallel -
sheets, -helices/random coils, and -turns, respectively [113-115]. The 
fibrils obtained in the absence of LUC exhibit two major peaks at 1630 cm-1 
and 1668 cm-1 with relative contributions of 50.2% and 29.8% and two minor 
peaks at 1619 cm-1 and 1650 cm-1 with 16.3% and 3.7%, respectively (Table 
2). The fibrils with LUC, on the other hand, gave rise to the two major peaks 
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at 1630 cm-1 and 1668 cm-1 with 58.0% and 29.7% and the two minor peaks 
at 1619 cm-1 and 1650 cm-1 with 7.6% and 4.7%, respectively. The results 
explain that the fibrils with LUC contain higher level of parallel -sheets with 
decreased anti-parallel -sheet content. 
 
1-3. Active conformation of luciferase plays a critical role on the 
acceleration of -synuclein fibrillation  
In order to confirm whether the enzymatic activity of LUC was essential for 
the acceleration of -synuclein fibrillation, the fibrillation kinetics were 
monitored with and without the inactivated LUC via pre-incubation at 37°C. 
As the pre-incubation proceeded, LUC was gradually inactivated to 30% of 
the original activity after 4 hours (Figure 14A). The decrease in LUC activity 
was accompanied with its structural change as assessed with 8-anilino-1- 
naphthalenesulfonic acid (ANS) binding fluorescence [116] (Figure 14B). As 
the enzymatic activity diminished, the fluorescence maximum at 460 nm 
increased, indicating an exposure of hydrophobic regions of LUC during the 
pre-incubation. In the presence of the 4 hour pre-incubated LUC, the 
enhancement of fibrillation was significantly suppressed in comparison with 
the fibrillation in the presence of fully active LUC even though the suppressed 
fibrillation was apparently faster than the kinetics observed with -synuclein 
alone. Therefore, these data were demonstrated that the accelerated 
fibrillation by LUC was dependent upon the biological activity and/or active 
conformation of the enzyme (Figure 14C).  

































Figure 14. Requirement of LUC activity for the accelerated -synuclein 
fibrillation. (A) LUC activity remaining after incubations at 37°C for 0, 30, 60, and 
240 min was examined with an emitted light at 550 nm. (B) ANS binding fluorescence 
of LUC after incubations at 37°C for 0, 30, 60, and 240 min. Fluorescence spectra 
of ANS was monitored between 400 and 600 nm with an excitation at 350 nm. (C) 
Fibrillation kinetics of -synuclein in the presence of active (black) and inactive (gray) 
LUC. -Synuclein (black) was separately incubated at 35 M as a control. (D) 
Fibrillation kinetics of -synuclein with LUC and substrates (luciferin and ATP-Mg2+). 
In the absence of LUC, -synuclein (35 M) was fibrillated without (○) and with the 
substrate of either 0.5 M luciferin (□) or 0.5 M ATP-Mg2+ (▽). The fibrillation 
kinetics of -synuclein was also monitored in the presence of LUC (0.1 M) without 





investigated in the presence of LUC’s substrates such as luciferin and ATP-
Mg2+. In the absence of LUC, neither luciferin nor ATP-Mg2+ at 0.5 M 
affected the fibrillation kinetics of -synuclein. With LUC at 0.1 M, 
however, luciferin increased the Th-T binding fluorescence at the stationary 
phase twice as much as the fluorescence obtained without the luciferin 
(Figure 14D). ATP-Mg2+, on the other hand, decreased the Th-T binding 
fluorescence by 0.8-fold from its absence. From these results, the active 
conformation of LUC which could be influenced by the substrates during the 
initial period of fibrillation appears to be crucial for the enhanced 
amyloidogenesis. 
 
1-4. Self-propagation of the altered morphology of -synuclein 
fibrils prepared with luciferase 
To clarify whether the newly developed morphology of the LUC-induced 
amyloid fibrils of -synuclein was transient or inherent to the fibrils, the self-
propagation experiment of amyloid fibrils was carried out. Previous studies 
demonstrated that the properties of amyloid fibrils can be transferred to 
subsequent daughter fibrils by introducing a small amount of amyloid 
fragments derived from their parent strands to a fibrillation process of 
amyloidogenic protein [117-119]. -Synuclein fibrillation was seeded at 5% 
(w/w) with the amyloid fragments obtained from the parent fibrils prepared 
in the presence and absence of LUC with sonication (Figure 15). In the 
presence of the seeds derived from the fibrils prepared without LUC, the lag 
period completely disappeared while the final Th-T binding fluorescence 
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reached to the same level as the fibrillation obtained without the seeds. In the 
presence of the LUC-induced seeds at 5% (w/w), on the other hand, the final 
Th-T binding fluorescence increased drastically by more than 4-folds, which 
was reminiscent of the accelerated LUC-induced -synuclein fibrillation as 
observed in Figure 13A. The lag phase, however, was also shortened 
significantly from the unseeded fibrillation, but it was definitely longer than 
the kinetics obtained with the seeds prepared in the absence of LUC. To 
confirm whether the increase in the final Th-T binding fluorescence was due 
to the altered morphology of amyloid fibrils instead of their actual quantity, 
the fluorescence intensity was divided by the mass of fibrils [120]. The result 
indicated that the fibrils derived with LUC-induced seeds yielded higher Th-
T binding fluorescence per mass of fibrils by two-fold than that of the fibrils 
obtained with the seeds prepared with -synuclein alone (Figure 15B). The 
data suggest that the increased Th-T binding fluorescence was not due to the 
actual amount of the fibrils but their altered properties reflected in the fibrillar 
morphology.  
 As morphologies of the final amyloid fibrils were examined with 
transmission electron microscope, structural characteristics of the paraental 
strands were transferred to their respective daughter fibrils. While rather 
straight and untangled fibrils were obtained for the daughter fibrils with the 
seeds prepared with -synuclein alone, the LUC-induced seeds produced the 
associative daughter fibrils which resembled the fibrils of -synuclein 
prepared in the presence of LUC (Figure 15D). This self-propagation property 






Figure 15. Self-propagation of the two amyloid polymorphs. (A) Fibrillation 
kinetics of -synuclein with the seeds at 5% (w/w). -Synuclein at 35 M was 
incubated in the absence (black open dot) and presence of the seeds prepared from 
either the -synuclein fibrils (black closed dot) or the LUC-induced fibrils (gray closed 
dot). (B) The Th-T binding fluorescence per mass of fibrils self-propagated in the 
presence of the seeds derived from either the -synuclein fibrils (black) or the LUC-
induced fibrils (gray). (C) TEM images of the -synuclein amyloid fibrils (top row) and 
the LUC-induced fibrils (bottom row) from the parent amyloid fibrils to their daughter 





synuclein fibrils derived with LUC became inherent to the fibrils.  
 
This study has shown that a single amyloidogenic protein turns into two 
different fibrils with distinctive morphologies. This difference of protein 
assembly has been achieved with a biologically active enzyme of luciferase. 
The process can be hypothesized that -synuclein exists in a kinetically 
trapped state from which the protein escapes by demolishing certain part(s) 
of the surrounding energy barrier. Once the protein surpasses the surrounding 
energy barrier, the protein might be stabilized into thermodynamically stable 
states via one or more pathways by yielding various forms of amyloid fibrils 
(Scheme 1). Both LUC and a transformed aggregative -synuclein might be 
able to lower the activation barrier by acting as a template for the pristine -
synuclein. The resulting two distinctive fibrils could directly work as the 
seeds in the fibrillation process, amplifying the amyloid fibrils.  
 In fact, all the data shown in this study illustrate that the fibrillar 
polymorphism has been directed by the seed generated by specific mutual 
interaction between -synuclein and the biologically active LUC. The 
observations including the drastically reduced lag phase of -synuclein 
fibrillation in the presence of LUC, the altered dye binding properties of the 
LUC-induced amyloid fibrils with thioflavin-T and JC-1, and the biochemical 
and morphological analysis of the fibrils with FT-IR and TEM support the 
seed-dependent alternative amyloid fibril formation. This phenomenon, 
therefore, emphasizes the significance of nucleation centers for amyloid fibril 













endowing those fibrils with certain biochemical properties. Those fibrils with 
unique properties, then, could be further amplified via the self-propagation 
procedure since the morphological characteristics become inherent to the 
newly developed fibrils.   
 This study, therefore, opens up a possibility that enzymes or even 
other biomolecules could have potentials to act as templates for 
amyloidogenic proteins like -synuclein, exhibiting the fibrillar 
polymorphism. By assuming that the cellular toxicity of amyloidogenic 
proteins could be associated the morphological and thus biochemical 
characteristics of amyloid fibrils in addition to the fact that those fibrils could 
be self-propagated, the diversified fibrils produced by a lot of biological 
partners could be considered as independent toxic causes.  
 
2. Mutual influences of -synuclein and glutathione peroxidase  
 
2-1. -Synuclein enhances antioxidant activity of glutathione 
peroxidase-1 
To investigate mutual interactions between -synuclein and GPX-1, an effect 
of -synuclein on the antioxidant activity of GPX-1 was first examined. The 
GPX-1 activity was monitored with a coupling system employing cumene 
hydroxide and GSH in the presence of glutathione reductase/NADPH [121]. 
The enzyme was pre-incubated with -synuclein at 4˚C for 20 min before 
assessed by observing the decrease in NADPH absorbance at 340 nm due to 
the reduction of GSSG back to GSH by glutathione reductase. Significant 
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enhancement of GPX-1 activity was observed with -synuclein (Figure 16). 
As shown the increased negative slopes reflecting enhanced NADPH 
consumption in Figure 16A, GPX-1 activity became continuously increased 
as -synuclein level increased. Neither glutathione reductase activity nor 
oxidation of NADPH was affected by -synuclein. Direct molecular 
interaction between -synuclein and GPX-1 was evaluated by plotting the 
initial activities of GPX-1 obtained as changes of moles of NADPH per min 
per mg protein as a function of -synuclein in molarity (Figure 16B). The 
enhanced GPX-1 activities exhibited a hyperbolic relationship with -
synuclein, indicating a possible specific binding between the two proteins. By 
performing a double reciprocal plot, their dissociation constant was estimated 
as 17.3 nM (Figure 16B, inset). The -synuclein-mediated enhancement of 
GPX-1 activity and the exceptionally high molecular affinity would suggest 
a novel physiological role of -synuclein in cellular anti-oxidative processes. 
In fact, a direct and tight interaction between the two proteins under 
physiological condition was demonstrated with immunocytochemical 
analysis of neuroblastoma cell-line, SH-SY5Y. Confocal microscopic images 
of immunofluorescence-stained cells with anti--synuclein and anti-GPX-1 
antibodies showed that both intrinsic proteins were found to be co-localized 
in SH-SY5Y cells (Figure 16C). Taken together, these results suggest a 
physiological function of -synuclein as a GPX’s natural partner in cellular 


















Figure 16. -Synuclein-mediated enhancement of GPX-1 activity. (A) GPX-1 
activities with increased -synuclein concentrations. GPX-1 (5 nM) was pre-
incubated with 0 (black), 56 (red), 112 (blue), 224 (cyan), 280 (green), and 560 nM 
(pink) of -synuclein at 4°C for 20 min, and the enzyme activity was monitored by 
observing the decrease in NADPH absorbance at 340nm. (B) Initial activities of GPX-
1 are plotted as a function of -synuclein in molarity. Double reciprocal plot was 
performed to obtain the dissociation constant between GPX-1 and -synuclein 
(inset). (C) Immunocytochemical analysis of SH-SY5Y neuroblastoma cell-line. Co-
localization of GPX-1 and -synuclein was visualized by staining cells with anti--












2-2. Glutathione peroxidase-1 accelerates amyloid fibrillation of -
synuclein 
Since GPX-1 was found to exist in -synuclein-enriched Lewy bodies [84], 
GPX-1 effect on the amyloidogenesis of -synuclein has been examined. By 
using typical kinetics study using thioflavin-T (Th-T) fluorescence assay, it 
was demonstrated that in vitro fibrillation of -synuclein was remarkably 
accelerated by GPX-1 in a dose-dependent manner (Figure 17A). Addition of 
GPX-1 at 0.05 M was sufficient to show the facilitated fibrillation of -
synuclein at 20 M by shortening the lag period and increasing the final Th-
T binding fluorescence. As the GPX-1 level increased twice, the lag further 
decreased from 40 hours to 20 hours. Moreover, the final Th-T binding 
fluorescence also increased by almost two-fold from that of the kinetics 
obtained with -synuclein alone. Based on the high affinity with Kd at nM 
range, the tight -synuclein-GPX-1 complex would provide a nucleation 
center for the accelerated and enhanced amyloidogenesis. 
 To demonstrate whether the activity of GPX-1 is crucial for the GPX-
1-mediated acceleration of -synuclein fibrillation, the fibrillation kinetics 
was carried out with GPX-1 in varying activities after pre-incubating the 
enzyme at 37°C by itself (Figure 17C). In the presence of the enzyme at 100%, 
50% and 25% of its activity, the shortened lag period was 13.1 hr, 15.6 hr and 
25.5 hr, respectively, whereas -synuclein required about 40 hr to be 
fibrillated in the absence of the enzyme (Figure 17B). In addition, the 

















Figure 17. GPX-1-mediated acceleration of the amyloid fibrillation of -
synuclein. (A) Aggregation kinetics of -synuclein in the presence of GPX-1. -
Synuclein (20 M) was incubated with 0.05 (▼) and 0.1 µM GPX-1 (△) at 37°C with 
vigorous shaking. Amyloid fibrillation was monitored by thioflavin-T binding 
fluorescence at 482 nm (emission at 450 nm) during incubation. -Synuclein (●) 
and GPX-1 (○) were separately incubated as controls. (B) GPX-1 activity-
dependency of the amyloid fibrillation of -synuclein. Partially inactivated GPX-1 was 
obtained at various time points during pre-incubation of the enzyme alone at 37°C. 
-Synuclein (20 M) was fibrillated with 0.1 M GPX-1 with decreasing activities 
from 100 % (○), 50 % (▼), and 25 % (△). (C) The time-dependent decrease of 
GPX-1 activity. GPX-1 alone was incubated at 37°C for 0 min, 30 min, 60 min, and 
120 min under quiescent condition. The enzyme activity was monitored by observing 
the decrease in NADPH absorbance at 340nm (n=3). (D) Amyloid fibrillation of -
synuclein in the presence of heat-inactivated GPX-1. 20 M -synuclein was 
incubated with active GPX-1 (○) and heat-inactivated GPX-1 (▼) at 37°C with 
vigorous shaking. Amyloid fibrillation was monitored by thioflavin-T binding 







proportionally decreased as the enzymatic was inactivated (Figure 17B). 
These findings clearly indicate that the biochemically active GPX-1 is 
required for the enzyme-mediated acceleration of -synuclein fibrillation by 
both shortening the lag phase and increasing the final fibrillation level. 
Addition of completely inactivated GPX-1 obtained via heating at 100˚C 
resulted in a fibrillation kinetics indistinguishable from that of -synuclein 
alone (Figure 17D).  
 
2-3. Entangled fibrillar aggregates of -synuclein acting as a depot 
for active GPX-1 
Morphological comparison of the final fibrillar aggregates of -synuclein 
obtained in the absence and presence of GPX-1 revealed that the fibrils 
resulted from the accelerated fibrillation with the enzyme were densely 
entangled (Figure 18A). Immunogold labeling was performed with anti-GPX-
1 antibody in order to evaluate the GPX-1 distribution within the 
entanglement. The enzymes were found to be locally clustered into the GPX-
1-islets within the fibrillar meshwork (Figure 18B). This entrapment of GPX-
1 into the -synuclein fibrils which has occurred during the in vitro 
fibrillation process is compatible with the previous observation of their co-
existence in the Lewy bodies of PD patient’s brain [84].  
 In order to examine the enzymatic activity of the entrapped GPX-1, 
the GPX-1-containing fibrils were resuspended in the assay mixture and the 
decrease of NADPH absorbance at 340 nm was monitored. Impressively, the 










Figure 18. Localization of GPX-1 within entangled -synuclein fibrils. (A) 
Morphologies of GPX-1-induced -synuclein fibrils. Scale bar, 0.5 m. (B) 
Distribution of GPX-1 within the entangled fibrils. Immunogold labeling was 
performed with anti-GPX-1 and gold-conjugated secondary antibodies. Dashed 
circles indicate GPX-1-islets. All samples for TEM analysis were negatively stained 





incubation of the fibrillation for 70 hr while the activity was almost 
completely vanished following only 2 hr of incubation at 37°C in the absence 
of the fibrils (Figure 19A and Figure 17C). The time course of the entrapped 
GPX-1 activity exhibited hysteresis, indicating that the NADPH consumption 
gradually increased as a function of time (Figure 19B). By plotting slopes of 
the tangent lines of the activity trace at various time points, the GPX-1 activity 
previously entrapped in the matrix was shown to increase linearly to its 
maximum during the initial 25 min, and then the activity remained unaffected 
until the substrate was completely consumed (Figure 19B, inset).  
 To account for the hysteresis in activity, the enzyme-entrapped 
fibrillar matrix was successively extracted with a fixed amount (100 L) of 
20 mM MES, pH 6.5, and the GPX-1 activity in the extracts was measured. 
Interestingly, the extracted activity also exhibited the hysteresis when 
compared with a control of GPX-1 (Figure 19C). As the extraction proceeded, 
the GPX-1 was continuously released in solution with subsequently 
diminished activities. In addition, the hysteresis became less apparent as the 
extracted GPX-1 activity decreased (Figure 19C, inset). This result indicates 
that the GPX-1 would be entrapped within the fibrillar matrix, which can be 
slowly activated upon its release. Moreover, the gradual increase in the GPX-
1 activity observed with the GPX-1 containing matrix (Figure 19B) would be 
also due to the slow release of the enzyme from the matrix. 
 
Based on findings, antioxidative function of -synuclein has been suggested 
















Figure 19. Enzymatic activity of the entrapped GPX-1. (A) Protection of GPX-1 
activity within the fibrillar matrix. GPX-1 activity was monitored after the -synuclein 
fibrillation was carried out in the presence of GPX-1 for 3 days at 37°C. Initial and 2 
hr-aged activities of GPX-1 at 37°C were shown as controls. (B) Time course of the 
entrapped GPX-1 activity. The GPX-1-containing fibrils were isolated by 
centrifugation at 16100 ×  g for 30 min, and resuspended in the GPX-1 assay 
mixture. The slope of the tangent lines of the activity trace was re-plotted at various 
time points (inset). (C) Reactivation of GPX-1 released from fibrils. Successive 
extraction of the GPX-1-entrapped fibrillar matrix was carried out with 100 mL of 20 
mM MES (pH 6.5) and each extract was subjected to the activity measurement. 
Black-dashed lines indicate initial and final activities of the released enzyme in the 
first extract. GPX-1 without the prior entrapment was used as a control (gray). The 
enzyme activities in the successive extracts were shown (inset); number indicates 






synuclein (Scheme 2). The H2O2-removing process of GPX-1 is significantly 
activated by interacting with -synuclein, and the -synuclein-GPX-1 
complex provides a possible nucleation center for the accelerated amyloid 
fibril formation of -synuclein, which results in the entangled filamentous 
aggregates with the GPX-1 deposited in a locally concentrated fashion. In 
addition, it has been previously reported that oxidized GSH (GSSG) also 
enhanced the amyloidogenesis of -synuclein [54]. Taken together, the 
physiological function of -synuclein and its amyloidogenesis can be 
understood with respect to the anti-oxidative GPX-1 system including 
glutathione turnover. Therefore, it can be considered that the mutual effects 
between -synuclein and GPX-1 would contribute to strengthen the cellular 
defense against toxic insults; as an activator of cellular GPX-1, -synuclein 
improves the enzyme’s antioxidant activity by removing toxic H2O2 with the 
formation of GSSG, and the resulting -synuclein-GPX-1 complex along 
with GSSG removes the toxic oligomers of -synuclein by facilitating the 
innocuous amyloid fibril formation [122]. Under pathological conditions, -
synuclein has been reported to be involved in the oxidative stress via causing 
mitochondrial dysfunction or direct generation of ROS from its aggregates 
[123-125]. In this report, however, it has been suggested that -synuclein 
might be a novel physiological partner of GPX-1, which improves the 
enzyme’s capability of preventing oxidative damages. Since a considerable 
amount of oxygen is consumed in brain tissues and the activity of GPX-1 in 

















to oxidative insults and PD may be exacerbated by the substantial decrease of 
GSH in the affected region of substantia nigra [126-128]. Therefore, it is 
hypothesized that abundant pre-synaptic -synuclein may complement the 
weakened antioxidant defense of nerve tissues by acting as an activator of 
cellular GPX-1. More surprisingly, it was also found that the GPX-1 
entrapped within the entangled fibrils retained most of its activity during the 
prolonged incubation, which could be slowly released and also partially 
activated. These facts would suggest that -synuclein fibrils can act as a 
biologically meaningful depot to retain GPX-1 in a latent form. Consequently, 
-synuclein and its fibrils could be considered to be involved in antioxidative 
processes within neuronal cells. Although the issue of toxic effects of amyloid 
fibrils is still controversial, these well-promoted pathological structures now 
could be conceptually transformed into a physiologically active component 
of cellular biogenesis.  
 
3. Effects of phenolic compounds on assembly of -synuclein 
 
3-1. Molecular interaction between -synuclein and phenolic 
compounds 
In order to examine the influences of phenolic compounds on -synuclein 
fibrillation, -synuclein was treated with three phenolic compounds (Figure 
20) which are abundant in daily foods such as red wine, curry and green tea. 
The molecular interaction between -synuclein and phenolic compounds 











Figure 20. Phenolic compounds of resveratrol, curcumin and (-)-





synuclein in the presence of resveratrol (RSV) (Figure 21A-a), curcumin 
(CUR) (Figure 21B-a) and (-)-epigallocatechin gallate (EGCG) (Figure 21C-
a) at various concentrations. Their interactions were verified by plotting the 
differences in the intrinsic fluorescence at 308 nm as a function of phenolic 
compounds concentration (Figure 21-b). In Figure 21C-a, emission peaks at 
around 380 nm indicate the intrinsic fluorescence of EGCG with excitation 
at 274 nm. The x-intercepts in double-reciprocal plots (Figure 21-b, inset) 
show that RSV, CUR and EGCG bind to monomeric -synuclein with a 
dissociation constant (Kd) of 30.4 M, 133 M and 100 M, respectively. 
Therefore, it has been clearly revealed that these phenolic compounds are -
synuclein interacting molecules. 
 
3-2. Interference of phenolic compounds in detecting amyloid 
formation with thioflavin-T binding fluorescence method. 
As shown in the Figure 21C-a, phenolic compounds exhibit individually 
intrinsic fluorescence (Table 3) because they are typical conjugated 
compounds resulting in strong  → * electronic transitions. For this reason, 
the thioflavin-T (Th-T) fluorescence assay is considered unsuitable for 
amyloid fibril detection in the presence of phenolic compounds [129]. In 
order to examine the interferences of phenolic compounds in Th-T 
fluorescence assay, fluorescence spectra from 460 nm to 600 nm were 
obtained with excitation at 450 nm after pre-made amyloid fibrils (AF) and 
Th-T were incubated for 5 min in the absence and presence of phenolic 















Figure 21. Molecular interaction between -synuclein and phenolic 
compounds. Tyrosine intrinsic fluorescence of -synuclein was monitored after 
coincubation with various concentration of resveratrol (RSV) (A-a), curcumin (CUR) 
(B-a) and (-) epigallocatechin gallate (EGCG) (C-a) for 30 min at 37°C. The 
differences in the intrinsic fluorescence at 308 nm were plotted as a function of 
phenolic compounds concentration (b). According to the x-intercepts in double-
reciprocal plots (b, inset), monomeric -synuclein binds to RSV, CUR and EGCG 























Figure 22. Effects of phenolic compounds on thioflavin-T (Th-T) fluorescence 
assay for detecting amyloid fibrils. (A) The Th-T fluorescence spectra in the 
absence (●) and presence of EGCG (○), CUR (▼) and RSV (△). The fluorescence 
spectra between 460 nm and 600 nm with excitation at 450 nm were obtained after 
pre-made amyloid fibrils and Th-T were incubated with EGCG, CUR and RSV for 5 





nm and exhibited fluorescence at 480 nm in the absence of phenolic 
compounds (●) and in the presence of RSV (△), clarifying that RSV did not 
affect the fluorescence of Th-T. In the presence CUR (▼), however, Th-T 
fluorescence quenching was occurred because CUR molecules totally 
absorbed the lights with wavelength both 450 nm and 480 nm (data not shown) 
and exhibited their fluorescence at 530 nm. Strangely, the Th-T fluorescence 
disappeared in the presence of EGCG although EGCG did not absorbed lights 
at 450 nm and 480 nm (Figure 22B). Taken together, it has been verified that 
Th-T fluorescence assay is not appropriate for monitoring the effects of 
phenolic compounds on the fibril formation.  
 In Figure 22, it was observed that EGCG specifically interrupted Th-
T binding fluorescence assay for detecting amyloid fibrils. This result showed 
that Th-T molecule might be hindered in binding to amyloid fibrils rather than 
its fluorescence was quenched by EGCG because EGCG did not absorb Th-
T emission light. In order to examine the effect of EGCG on binding of Th-T 
to amyloid fibrils, Th-T fluorescence was monitored in the presence of EGCG 
at various concentration (Figure 23). Pre-made amyloid fibrils at 7 M were 
incubated with 2.5 M of Th-T and various concentration of EGCG for 5 min 
in the dark and the emission spectra of mixtures were obtained with excitation 
at 450 nm (Figure 23A). According to the graph of differences of Th-T 
fluorescence at 482 nm as a function of EGCG concentration (Figure 23B), 
Th-T fluorescence decreased as EGCG concentration increased with half 
maximal inhibitory concentration (IC50) of 0.044 mM. 










Figure 23. Interference of EGCG in Th-T binding fluorescence assay for 
detecting amyloid fibrils. (A) Fluorescence spectra were obtained after Th-T and 
amyloid fibrils interacted with various concentration of EGCG for 5 min in the dark. 













Figure 24. Effects of EGCG on -synuclein amyloid fibrils. After incubation with 
EGCG for 1 hr at 37°C, -synuclein amyloid fibrils were analyzed by dynamic light 





caused by EGCG-induced disintegration and structural alteration of amyloid 
fibrils, -synuclein fibrils were post-treated with EGCG for 1 hr at 37°C and 
analyzed with dynamic light scattering (DLS) system, transmission electron 
microscopy (TEM), circular dichroism spectroscopy (CD) and Fourier 
transform-infrared spectroscopy (FT-IR) (Figure 24). First of all, according 
to the results from DLS (Figure 24A) and TEM (Figure 24B), the size 
distribution and morphology of amyloid fibrils were not affected by EGCG, 
clarifying that amyloid fibrils were not fragmented by EGCG. By 
investigating with CD (Figure 24C) and FT-IR (Figure 24D), it was also 
observed that post-incubation with EGCG did not induce the structural 
changes of amyloid fibrils. Taken together, it can be considered that EGCG 
molecules may interact with amyloid -sheets in competition with Th-T 
molecules, resulting the decrease of Th-T fluorescence in the presence of 
EGCG.  
 
3-3. Phenolic compounds have influences on fibrillation of -
synuclein 
In order to verify the phenolic compounds effects on fibrillation of -
synuclein, time-resolved -synuclein assembly in the absence and presence 
of phenolic compounds was monitored by using SDS-PAGE and Coomassie 
Brilliant Blue staining (Figure 25). First of all, the amount of -synuclein 
monomers decreased and protein band smearing was observed with time in 
the absence and presence of phenolic compounds. These results demonstrated 











Figure 25. Time-resolved SDS-PAGE analysis of fibrillation of -synuclein in 
the absence and presence of phenolic compounds. -Synuclein monomer (70 
M) was incubated at 37°C for the indicated intervals without (A) and with 350 M of 
RSV (B), CUR (C) and EGCG (D). SDS-resistant aggregates of -synuclein were 





whereas several studies have reported the inhibitory effects of phenolic 
compounds on fibrillation [130, 131]. In other words, RSV (Figure 25B) and 
CUR (Figure 25C) were shown to accelerate rather than prevent the 
aggregation of -synuclein. EGCG, meanwhile, facilitated the formation of 
SDS-resistant and compact oligomers (Figure 25D) through off-pathway 
aggregation as previously reported [132]. Moreover, SDS-PAGE analysis 
shows that degradation of -synuclein was completely inhibited with  
phenolic compounds during the prolonged incubation. When -synuclein 
was incubated alone, fragments of -synuclein emerged as protein bands 
below 14 kDa (Figure 25A), whereas -synuclein was entirely protected from 
degradation through co-incubation with phenolic compounds. According to 
TEM images in Figure 26A, RSV, CUR and EGCG are shown to have little 
effect on assembly of -synuclein into amyloid fibril structures and then 
morphology of amyloid fibrils seems to equal each other. However, the 
amount of amyloid fibrils and -sheet contents in end products were affected 
by phenolic compounds treatment. To compare -sheet propensity of these 
end products, analysis of CD spectra was performed by using convex 
constraint algorithm (CCA) (Table 4). First of all, amyloid fibrils of -
synuclein incubated alone are composed of -sheet and -turn (29.1%) and 
random coil (70.9%). However, aggregates prepared with RSV have 
considerable contents of -sheet and -turn structure (42%) and random coil 
(58.0%) structures. Furthermore, aggregates of -synuclein with CUR are 








Figure 26. Effects of phenolic compounds on the morphology and structure of 
-synuclein amyloid fibrils. (A) TEM images of -synuclein amyloid fibrils 
prepared without and with RSV, CUR and EGCG. Scale bars represent 0.5 m. (B) 
Circular dichroism spectra of -synuclein amyloid fibrils prepared without (●) and 
with RSV (○), CUR (▼) and EGCG (△). -Synuclein and phenolic compounds were 
coincubated for 130 hr at 37°C with agitation and the end products were precipitated 















Table 4. Secondary Structure contents of -synuclein amyloid fibrils prepared 






random coil (59.2%). According to SDS-PAGE analysis and CD spectrum, 
few precipitates were obtained after incubation of -synuclein with EGCG 
because most -synuclein remained soluble and monomeric proteins. End 
products from -synuclein and EGCG have substantial contents of -helix 
(16.3%) and -sheet and -turn structure (57.1%) with low random coil 
contents (26.5%). Therefore, CD spectra show that phenolic compounds may 
promote the formation of -sheet amyloid fibrils, inducing the fibrillar 
polymorphism. Taken together, therapeutic effects of phenolic compounds 
may be displayed by the acceleration of -synuclein self-assembly and 
removal of toxic -synuclein species and then inducing the fibril 
polymorphism. 
 
This study has suggested that the phenolic compounds can play a role as a 
partner molecule for -synuclein and have promising therapeutic potential in 
Parkinson’s disease (PD). For example, resveratrol, curcumin and (-)-
epigallocatechin gallate interact with -synuclein molecules and have 
significant influences on self-assembly of -synuclein, inducing the fibril 
polymorphism (Scheme 3). In other words, the formation of high -sheet 
contents amyloid fibrils demonstrates that the phenolic compounds may 
prevent the formation of toxic on-pathway -synuclein species and then result 
in less toxic off-pathway -synuclein aggregates. These results suggest that 
















4. Control of the unit assembly of -synuclein active oligomers 
 
4-1. Definition of -synuclein active oligomer 
 
4-1-1. Fibrillation of -synuclein 
Intermediates of amyloid fibrillation which are called as oligomer or 
protofibrils are usually observed in the early phase of fibrillation. In this study, 
specific oligomer species among intermediates of -synuclein fibrillation are 
defined as active oligomer and characterized in detail.  
 First of all, the kinetics of -synuclein fibrillation monitored by using 
Th-T binding fluorescence is characterized by an ‘S-shaped’ sigmoidal curve 
(Figure 27A). As shown in TEM images (Figure 27B), monomers (i) are 
assembled into oligomers (ii), and then grow into amyloid fibrils (iii). 
According to the fibrillation kinetics and TEM images, most proteins in gray 
region in Figure 27A may be oligomeric intermediates and specific oligomers 
among them are prone to be affected by chemical and mechanical effects.  
 
4-1-2. Active oligomers are rapidly assembled into curly amyloid fibril 
(CAF) via repetitive membrane filtration 
To observe the unit assembly of distorted oligomers and the formation of 
curly amyloid fibrils (CAF), fibrillation intermediates are analyzed with Th-
T binding fluorescence (Figure 28A) before and after they were repetitively 
filtered through centrifugal membrane at 14000 g for 10 min. As a results, 










Figure 27. Fibrillation of -synuclein. (A) Kinetics of -synuclein fibrillation 
monitored with Th-T binding fluorescence. -Synuclein (1 mg/mL) was incubated at 
37°C with agitation. (B) TEM images of monomers (i), intermediates (ii) and fibrils (iii) 











Figure 28. The formation of curly amyloid fibrils was monitored by using dye 
binding fluorescence. Intermediates on fibrillation were analyzed with Th-T (A) and 
JC-1 (B) binding fluorescence before (white) and after (black) repetitive membrane 
filtration with centrifugation at 14000 g for 10 min. When fluorescence dyes interact 
with -sheet structures, Th-T emits fluorescence at 482 nm with excitation at 450 nm 






3-fold at the first time after membrane filtration. This result means that 
mechanical effect through repetitive membrane filtration facilitated the unit 
assembly of oligomers and fibril formation. Rapid fibrillation by membrane 
filtration was also observed by JC-1 binding fluorescence (Figure 28B). 
According to the previous study [109], JC-1 could discriminate monomer, 
oligomeric intermediates and fibrils on fibrillation pathway by emitting the 
enhanced fluorescence at 590, 560 and 538 nm, respectively with excitation 
at 490 nm. After the intermediates at 6 hr were repetitively filtered through 
centrifugal membrane, fluorescence at 538 nm ascended 3-fold, 
corresponding to unit assembly of oligomers and rapid fibrillation. The unit 
assembly of oligomers under mechanical stress induced the amyloid 
polymorphism and developed curly amyloid fibrils (CAF) unlike straight 
amyloid fibrils (SAF) generally produced via nucleation-dependent 
fibrillation pathway (Figure 29). 
 
4-1-3. Radiating amyloid fibril formation (RAF) of active oligomer on 
the surface of lipid membrane 
Unit assembly of -synuclein oligomers on the surface of liposome can lead 
to radiating amyloid fibril (RAF) formation and membrane disruption. 
Liposome containing DOPC (Figure 30A) which is a major component of 
biological membranes and neutral lipid can react with oligomeric 
intermediates only. When DOPC liposomes were incubated with -synuclein 
monomers (Figure 30B) and fibrils (Figure 30D), intact liposomes were 










Figure 29. TEM images of straight amyloid fibrils (SAF) and curly amyloid 












Figure 30. TEM images of radiating amyloid fibril (RAF) formation on the 
phosphatidylcholine (PC) liposome and lipid membrane disruption through unit 
assembly of -synuclein active oligomers. PC liposomes were incubated with MES 
buffer (A), -synuclein monomers (B), active oligomers and fibrils (D) for 15 min at 






oligomers were incubated for 15 min, RAFs were formed on the surface of 
DOPC liposomes and the lipid membranes were disrupted (Figure 30C). 
According to previous studies, it has been demonstrated that unit assembly of 
oligomers on the liposome surface mechanically pulled lipid molecules out 
and then destroyed the structure of liposome, corresponding to -synuclein 
oligomer toxicity to cell membrane.  
 Furthermore, lipid membrane disruption by active oligomers is  
dramatically enhanced under pathological condit ions such as high 
temperature and high cholesterol contents. (Figure 31). First of all, the 
percentage of disrupted liposomes increased as cholesterol level increased. 
The 16.4%, 22.3% and 26.4% of liposomes with cholesterol at 0% (w/w), 
10% and 20%, respectively are disrupted at 25°C. Furthermore, the RAF 
formation and liposome disruption remarkably increased from 20.6 % to 
57.6%, from 21.4% to 59.7% and from 41.5% to 70.9% with temperature 
increase from 37°C to 40°C. Therefore, it can be considered that high fever 
which is a typical feature of inflammation is closely related to cell membrane 
disruption by active oligomers of -synuclein. Also, higher cholesterol level 
in lipid membrane is associated with increase of membrane disruption 
induced by active oligomers. This results may be caused by direct binding of 
-synuclein to cholesterol in lipid membrane [133]. In fact, brain cholesterol 
is an essential component of all mammalian cell membranes, and it has a 
critical role in central nervous system processes such as synaptogenesis [134] 
and myelin formation [135]. However, the dysregulation of cholesterol 









Figure 31. RAF formation and PC lipid membrane disruption by active 
oligomers under pathological conditions such as high temperature and high 




[136-138]. Furthermore, several studies about the effect of cholesterol-
depleting agent on models of Parkinson’s disease have shown that decrease 
of cholesterol levels can reduce the levels of -synuclein accumulation in 
neuronal membranes [139, 140]. Therefore, high cholesterol level in lipid 
membrane may be a risk factor and a therapeutic target for Parkinson’s 
disease.  
 
Taken together, ‘active oligomer’ is designated as oligomeric species which 
meet all of the requirements as follows: (1) Active oligomers should be -
sheet free intermediates formed in early phase of fibrillation; (2) They can be 
assembled into CAF through repetitive membrane filtration (Scheme 4A); (3) 
When they are incubated with PC liposome, RAF will be instantly developed 
on the surface of lipid membranes, resulting in membrane disruption (Scheme 
4B).  
 
4-2. Effects of -synuclein interactive molecules on the unit-
assembly of active oligomer 
 
4-2-1. Curly amyloid fibril formation in the presence of -synuclein 
interactive molecules  
In order to find an effective modulator for unit assembly of -synuclein active 
oligomer, curly amyloid fibrils (CAF) were developed via repetitive 
membrane filtration in the presence of several molecules examined 








Scheme 4. Unit assembly of -synuclein active oligomer. (A) The formation of 
curly amyloid fibril (CAF) via repetitive membrane filtration. (B) The formation of 











Figure 32. The formation of CAF in the absence and presence of -synuclein 
interactive molecules. Prior to repetitive membrane filtration, active oligomers were 
coincubated with -synuclein interactive molecules for 3 hr 37°C with agitation. Scale 





active oligomers were incubated for 3 hr at 37°C in orbital shaker with GPX-
1 (0.1 M), LUC (0.1 M), EGCG (350 M), CUR (350 M) and RSV (350 
M). After additional incubation, -synuclein oligomers remained spherical 
and amyloid fibrils were not observed in the absence of -synuclein 
interactive molecules and in the presence of LUC, GPX-1, CUR and RSV. 
However, in the presence of EGCG, almost oligomers were assembled into 
aggregates and amyloid fibrils, resulting the removal of active oligomers. 
 Furthermore, the TEM images after repetitive membrane filtration 
show that GPX-1 did not affect the unit assembly of active oligomers and the 
formation of CAF was clearly observed. On the other hand, LUC and phenolic 
compounds significantly influenced on unit assembly and CAFs were not 
observed in TEM images. In particular, EGCG extremely accelerated the unit 
assembly of active oligomers and did not allow active oligomers to be 
structurally distorted and develop into CAF through membrane filtration. 
Active oligomers with CUR and RSV were not completely assembled into 
CAF and a large portion of active oligomers remained as oligomeric species. 
Therefore, these data show that EGCG is the most effective molecule to 
control the unit assembly of active oligomer and have a possibility to reducing 
neurotoxicity of active oligomers.  
 
4-2-2. Radiating amyloid fibril formation in the presence of EGCG 
EGCG can inhibit active oligomer-induced disruption of lipid membrane by 
facilitating intermolecular interaction between active oligomers (Figure 33). 










Figure 33. TEM images of PC liposomes after incubation with active oligomers 
and various concentration of EGCG for 0 min, 15 min and 30 min. Scale bars 








disrupted by interacting with active oligomer and RAFs are formed on the 
surface of liposome after incubated for 30 min. In the presence of EGCG, 
however, intact liposomes are observed after coincubation for 30 min and 
aggregates and amyloid fibrils of -synuclein are found around the liposomes 
instead of RAF on lipid membrane surface.  
 In order to examine the effect of EGCG on cultured cell, human 
dopaminergic neuroblastoma cells (SH-SY5Y) were incubated with active 
oligomers and EGCG for 24 hr (Figure 34). First of all, decrease of cell 
viability as a function of concentration of active oligomers demonstrates in 
vitro cytotoxicity of -synuclein active oligomers (Figure 34A). When SH-
SY5Y cells were incubated with 7 M of active oligomers and EGCG at 
various concentration (Figure 34B), cell viability slightly increased from 
62.5% to 74.7% in the presence of 35 M of EGCG. According to these 
results, EGCG binds to -synuclein and facilitates intermolecular interaction 
between active oligomers, inhibiting that active oligomers mechanically 
affect cellular compartments such as cell membrane. Taken together, it is 
confirmed that -synuclein active oligomers may be neurotoxic and EGCG 
can work as a therapeutic agent for reducing cytotoxicity of active oligomers.  
 
In this study, it has been verified that unit assembly of -synuclein active 
oligomers is controlled by several -synuclein interactive molecules such as 
firefly luciferase, glutathione peroxidase, resveratrol, curcumin and (-)-
epigallocatechin gallate (EGCG) (Scheme 5). These molecules interact with 









Figure 34. Cytotoxicity of active oligomers and EGCG-induced reduction in 
cytotoxicity. (A) SH-SY5Y cells (~ 1.0 x 106 cells/mL) were treated with various 
concentration of active oligomers and incubated for 24 hr at 37°C in the CO2 
incubator. (B) SH-SY5Y cells were treated with active oligomers at 7 M and EGCG 
at various concentration and incubated for 24 hr at 37°C in the CO2 incubator. Cell 
viability was analyzed by using colorimetric MTS assay and absorbance of reduced 


















amyloid fibrils (CAFs) via repetitive membrane filtration. Particularly, 
EGCG has the most dramatic effects on the unit assembly of active oligomers 
by facilitating the interaction between -synuclein active oligomers. This 
EGCG-induced rapid intermolecular interaction allowed active oligomers to 
avoid mechanical stress caused by repetitive membrane filtration and the 
CAF formation. It has been also observed that active oligomers post-treated 
with EGCG cannot disrupt the lipid membrane through the formation of 
radiating amyloid fibrils on the surface of liposome. Furthermore, the cell 
viability test showed that these EGCG effects can reduce the cytotoxicity of 
-synuclein active oligomers. Taken together, many -synuclein interactive 
biomolecules and natural compounds are expected to influence unit assembly 




-Synuclein, intrinsically unstructured protein, can bind multiple ligands. In 
this study, several -synuclein interactive molecules have been studied and 
their biological and therapeutic implications have been suggested.  
(1) Interaction between LUC and -synuclein (Kd = 8.1 M) contributes to 
enhance the bioluminescence activity of LUC and the fibrillation of - 
synuclein. Also, complex of LUC and -synuclein work as a novel 
nucleation center, inducing amyloid polymorphism.  
(2) Interaction between GPX-1 and -synuclein (Kd = 17.3 nM) contributes 
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to boost antioxidant activity of GPX-1 and the fibrillation of -synuclein. 
Furthermore, the novel function of -synuclein and entangled -
synuclein fibrils have been suggested as a activator for antioxidative 
system and depot for active GPX-1, respectively. 
(3) Phenolic compounds such as resveratrol, curcumin, EGCG bind to -
synuclein monomers and promote the formation of -sheet rich amyloid 
fibril, resulting in the fibril polymorphism. In particular, EGCG induces 
the formation of compact oligomer of -synuclein via off-pathway 
assembly. 
(4) Specific oligomer species of -synuclein defined as active oligomer are 
affected by several -synuclein interactive molecules.  
   (4-1) In the presence of LUC, RSV, CUR and EGCG, the formation of 
CAF was inhibited. 
   (4-2) Especially, EGCG dramatically accelerated the unit assembly of 
active oligomers, showing the enhanced intermolecular assembly 
of -synuclein active oligomers. 
   (4-3) RAF formation and lipid membrane disruption by active oligomer 
are noticeably reduced by additional treatment of EGCG. 
(5) Also, EGCG has a significant effect on reducing the cytotoxicity of active 
oligomer. 
In summary, -synuclein interactive molecules have biological and  
therapeutic implications through accelerating the fibrillation, inducing the 






Part II. Colorimetric Sensor Development with -




1. Polydiacetylene-based colorimetric sensors 
 
Colorimetric sensing materials have been valued for easy and convenient 
detection of environmental signals. Polydiacetylene (PDA) has been widely 
employed to monitor color-transition caused by external stimuli such as 
temperature, pH, solvents, ions, and ligand-receptor interactions [141-143]. 
PDA-based sensors are prepared via ordered structures of diacetylene 
monomers. 10,12-Pentacosadiynoicacid (PCDA) is a diacetylene monomer 
comprised of a carboxylic group with along aliphatic chain containing two 
triple bonds, whose structure is reminiscent of fatty acids in nature. Well-
ordered PCDA monomers are polymerized via 1,4-addition reaction by UV 
irradiation at 254 nm (topochemical photopolymerization) and the 
polymerized PCDA (poly-PCDA) with alternating double and triple bonds 
(ene-yne) (Figure 35) exhibit blue in color [144-146]. When poly-PCDA is 
exposed to the external stimuli, the blue-to-red color transition and a related 
phenomenon of fluorescence enhancement occur via structural relaxation of 
the strained ene-yne conjugation of the PCDA molecules. It is this unique 
















various sensing applications including biosensors detecting microorganism 
[147], membrane interaction of casein oligomers [148], and gas like NH3 and 
its derivatives [149, 150]. In order to improve its sensing properties and thus 
expand the fields of application, the PDA vesicles have been further modified 
by conjugating with phenolate [151], biotin [152], and KTTKS peptide from 
collagen [153]. Although the PDA-based colorimetric materials have readily 
been produced in vesicles, the vesicular structures suffer from vulnerability 
to mechanical stress and deterioration via aggregation in the presence of 
water-soluble polymers [154] and cations such as Ca2+ and Na+ [155-157]. 
 
2. Amyloid fibrils in material science 
 
Amyloids, a common pathological phenomenon observed in various 
neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s 
disease, and amyotrophic lateral sclerosis [158, 159], are insoluble fibrous 
protein aggregates produced via self-assembly of soluble proteins. Amyloid 
fibrils are produced by forming highly ordered cross -sheet conformation, 
which result in straight and long nanofibrils with an average width centered 
at 10 nm [160-163]. From the perspective of materials, amyloid fibrils 
become an attractive biomaterial because of not only their mechanical 
strength shown to be comparable to steel [164], but also they can be readily 
manipulated to yield amyloid-based nanowire [165], nanostructured protein 
film [166], and hollow nanotubes [167]. Additionally, other types of amyloid-
based biomaterials have been reported to be produced, which include pea-pod 
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type gold nanoparticle chain with in amyloid fibrils [168], conductive 
nanowire networks [169], thermo-reversible amyloid fibrils [170], and 
enzymatically active fibrils [171]. Herein, the amyloid-based colorimetric 
material was made of -synuclein and PCDA by simply co-incubating both 
components.  
 
II. Experimental Section 
 
1. Oligomerization of -synuclein in the presence of 10,12-
pentacosadiynoic acid (PCDA) 
 
The oligomerization of -synuclein was examined in the presence of various 
concentrations of PCDA monomer by using an EEDQ cross-linker. The 
oligomers were revealed as discrete ladders on a silver-stained 10−20% 
Tricine SDS-PAGE gel. -Synuclein (35 M) was preincubated with various 
concentrations of PCDA in 20 mM MES (pH 6.5) containing 5% DMSO for 
30 min at 25°C. Following the addition of 0.3 mM EEDQ, the mixture was 
further incubated for 1 h at 25°C. Each sample was combined with the tricine 
sample buffer containing 24% (v/v) glycerol, 8% (w/v) SDS, 0.015% CBBG, 
and 0.005% phenol red in 0.3 M Tris/HCl at pH 8.45 in a 1:1 (v/v) ratio, 
boiled for 5 min, and analyzed with the precast 10−20% tricine gel. 
 




-Synuclein (35 M) was preincubated in the absence and presence of 
various concentrations of PCDA for 30 min at 37°C, and the intrinsic tyrosine 
fluorescence of -synuclein was monitored at 304 nm with excitation at 274 
nm by using a chemiluminescence spectrophotometer (LS-55B, PerkinElmer). 
A saturation curve was obtained by plotting the difference in the intrinsic 
fluorescence obtained in the absence (I0) and presence (Ii) of PCDA as a 
function of PCDA concentration. Dissociation constant Kd was obtained from 
the x-intercept of a double-reciprocal plot of the hyperbolic saturation curve 
between 1/[PCDA] and 1/(I0 − Ii) on the x and y axes, respectively. 
 
3. Fibrillation of -synuclein in the absence and presence of PCDA 
 
The fibrillation of -synuclein was monitored by Th-T binding fluorescence 
and the amount of protein remaining in the supernatant. -Synuclein (35 M) 
was incubated in 20 mM MES (pH 6.5) containing 5% (v/v) DMSO at 37°C 
under shaking at 200 rpm. During the incubation, an aliquot (20 L) of -
synuclein was reacted with 2.5 M Th-T in 50 mM glycine (pH 8.5) for 5 min 
at room temperature. Th-T binding fluorescence at 485 nm with excitation at 
450 nm was monitored with a chemiluminescence spectrophotometer (LS -
55B, PerkinElmer). To quantify soluble -synuclein remaining in the 
incubation mixture, the amyloid fibrils were precipitated with centrifugation 
at 16,100g for 30 min. The amount of soluble -synuclein left in the 
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supernatant was measured with a microbicinchoninic acid (BCA) protein 
assay kit (Thermo Fisher Scientific Inc.) [172]. Fibrillation of -synuclein 
(35 M) in the presence of PCDA at various concentrations was monitored 
by measuring the turbidity of the incubation mixture at 405 nm with a 
UV/visible spectrophotometer (Ultrospec 2100 pro, GE Healthcare). A 
mixture of -synuclein and PCDA was incubated in 20 mM MES (pH 6.5) 
containing 5% (v/v) DMSO at 37°C under shaking at 200 rpm. 
 
4. Preparation and characterization of AF/PCDA  
 
After the incubation of -synuclein and PCDA in 20 mM MES (pH 6.5) 
containing 5% (v/v) DMSO at 37°C for 100 hr, AF/PCDA was isolated in the 
precipitates through repetitive centrifugation at 16 100g for 30 min and 
washing with distilled water. The collected AF/PCDAs were subjected to UV 
light exposure at 254 nm for 10 min and heat treatment at 80°C for 10 min. 
The morphological features and fluorescence property of AF/PCDA were 
analyzed by transmission electron microscopy (TEM) and confocal laser 
scattering microscopy (CLSM), respectively. AF/PCDA were absorbed onto 
a carbon-coated copper grid (200-mesh, Electron Microscopy Sciences) and 
dried in air for 3 min. Following negative staining with 2% uranyl acetate 
(Electron Microscopy Sciences) for 5 min, the grids containing AF/PCDA 
were visualized with TEM (JEM-1010, JEOL). AF/PCDAs on a glass slide 
were examined with CLSM (LSM 710, Carl Zeiss) to observe the fibrillar 
fluorescence with excitation at 405 nm. UV/vis absorption spectra of the 
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colorimetric response of AF/PCDA were obtained by scanning the samples 
with a UV/visible spectrophotometer from 450 to 750 nm (Ultrospec 2100 
pro, GE Healthcare).  
 
5. Preparation of poly-PCDA vesicles  
 
PCDA was dissolved in chloroform to 0.5 mg/mL, and then the solution was 
blown with inert nitrogen gas while being vortex mixed. After complete 
removal of the chloroform, a thin film layer of PCDA was formed on the inner 
surface of a glass tube and the sample was frozen at −20°C. The dried PCDA 
film was then hydrated simply by dissolving it in distilled water to the same 
volume as for the chloroform, resulting in a translucent solution. PCDA 
vesicles were produced by prewarming the solution to 75°C for 20 min, 
followed by bath sonication for another 30 min at the same temperature. After 
sonication, the solution was filtered through a microfilter with a pore size of 
0.45 m, which was subsequently stored at 4°C overnight. Finally, the PCDA 
vesicle solution was polymerized with UV exposure at 254 nm for 5 min, and 
the color transition to blue confirmed that the reaction had taken place. 
Prepared poly-PCDA vesicles was examined with TEM (Figure 36A) and 
UV/vis absorptions between 450 nm and 750 nm (Figure 36B).  
 
6. Colorimetric responses of AF/PCDA and poly-PCDA vesicles to 








Figure 36. Preparation of the solution of PCDA vesicles. (A) TEM images of 
PCDA monomers and PCDA vesicles in solution. The scale bars represent 200 nm. 







Aliquots of AF/PCDA and poly-PCDA vesicles were placed into Eppendorf 
tubes, and they were separately incubated at different temperatures from 25 
to 90°C for 20 min to reach equilibrium. Following incubation, their UV/vis 
absorptions were monitored from 450 to 750 nm. To verify the colorimetric 
transitions of AF/PCDA and poly-PCDA vesicles at different pH, the 
solutions were prepared at different pH values from 2.2 to 12.4 by adding 1 
N HCl and 1 N NaOH. For the colorimetric response to ethanol, AF/PCDA 
and poly-PCDA vesicles were also prepared at different % ethanol 
concentrations. After 30 min of incubation, UV/vis absorption spectra of 
AF/PCDA and poly-PCDA vesicles were also obtained for both pH- and 
ethanol-treated samples. To quantify the blue-to-red color transition, the % 
colorimetric response (%CR) was calculated according to the equation %CR 
= [(PB0 − PB)/PB0] × 100 [173]. The PB denoting percent blue is calculated 
from A650/(A550 + A650), where A550 and A650 are the maximum peaks of 
absorption spectra of red and blue phases, respectively. PB0 represents the 
initial percent blue obtained before any exposure to the stimuli.  
 
7. Mechanical stability of AF/PCDA, poly-PCDA vesicles, and AF 
against sonication 
 
AF/PCDA, poly-PCDA vesicles, and AF were sonicated with a microtip-
typeultrasonic processor (VCX 750, Sonics & Materials Inc.) at 20 kHz under 
750 W with an on/off cycle of 10 s each. Following every 20 on/off cycle of 
sonication in ice, the absorption spectra of AF/PCDA and poly-PCDA 
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vesicles were monitored to a maximum of 80 cycles. Furthermore, the fibrillar 
states of AF and AF/PCDA were examined with TEM (JEM1010, JEOL) 
during the sonication.  
 
8. Preparation of litmus-type sensors with amyloid fibrils and PCDA 
 
The amyloid fibril and PCDA composites (AF/PCDA) were prepared by 
incubating monomeric -synuclein (70 M) for 70 hr at 37°C in the presence 
of PCDA at 1 mM under agitation at 200 rpm. The resulting AF/PCDA were 
collected via centrifugation at 16100 × g for 30 min. The mixture between 
pre-made amyloid fibrils and PCDA (AF+PCDA) was obtained by incubating 
the pre-made amyloid fibrils of -synuclein and PCDA (1 mM) for 15 min at 
ambient temperature. The AF+PCDA were also precipitated with the 
centrifugation. The collected pellets of AF/PCDA and AF+PCDA were 
resuspended with 200 L of 20 mM Mes (pH 6.5). Aliquots (10 L) of 
AF/PCDA and AF+PCDA solutions were dropped onto Whatman filter paper 
and air-dried for 2 hours. The spots of AF/PCDA and AF+PCDA on the filter 
paper turned to blue in color after UV exposure at 254 nm for 1 min. 
 
9. Colorimetric and fluorescent responses of the litmus-type sensors to 
temperature and organic solvents 
 
Litmus-type sensors prepared with AF/PCDA and AF+PCDA were either 
incubated at different temperatures from 25°C to 90°C for 5 min or exposed 
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to various organic solvents in vapor or liquid. The colorimetric change of 
litmus-type sensors was recorded with digital camera and the fluorescence 
enhancement was analyzed with confocal laser scattering microscopy (CLSM, 
LSM 710, Carl Zeiss) with excitation at 405 nm. In order to quantitatively 
analyze the fluorescence enhancement, the fluorescence intensity of the spots 
was evaluated with microscope and imaging software provided by Carl Zeiss. 
 
10. Monitoring of heat progress and detection of localized heating 
 
Following UV exposure, the litmus-type AF+PCDA sensor was put on top of 
a hot plate steadily heated from 25°C to 60°C and monitored for its color 
transition from blue to red. In order to apply a localized heat to the litmus-
type sensor, the copper tape was glued on the back of the paper sensors in a 
musical sharp sign and heated to 120 ˚C with a hot plate.  
 
11. Tightness of the PCDA binding to amyloid fibrils 
 
The collected AF/PCDA and AF+PCDA were resuspended with 200 L of 
20 mM Mes (pH 6.5) and sonicated with micro-tip-type ultrasonic processor 
(VCX 750, Sonics & Materials Inc.) for 2 sec at 20 kHz under 750 W. 
Following the removal of free PCDA molecules unleashed from the amyloid 
fibrils with centrifugation at 16100 x g for 30 min, the precipitated AF/PCDA 
and AF+PCDA were again resuspended with 20 mM Mes (pH 6.5). 
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Aliquots(10 L) of the AF/PCDA and AF+PCDA solutions were dropped 
onto Whatman filter paper, air-dried for 2 hours, and exposed to UV light at 
254 nm for 1 min. The sonication step was repeated until the blue-dots did 
not appear on the paper upon the UV exposure. 
 
III. Results and Discussion 
 
1. Stimuli-responsive biomaterials from -synuclein amyloid fibril 
 
1-1. Molecular interaction between -synuclein and PCDA 
To demonstrate specific interaction between -synuclein and PCDA, self-
oligomerization of -synuclein was evaluated in the presence of various 
concentrat ions of PCDA by using a cross -linker of 2-ethoxy-1-
ethoxycarbonyl-1,2-dihydroquinoline (EEDQ) [44, 53, 174]. The -
synuclein oligomers induced by PCDA were revealed in a discrete ladder 
formation on a silver-stained 10-20% Tricine SDS-PAGE gel (Figure 37A). 
The ladder formation started to appear from 0.1 mM PCDA and became 
apparent from 0.5 mM, indicating that -synuclein was specifically 
influenced by PCDA to be self-assembled into the oligomers. In addition, 
their specific interaction was reassessed with a saturation binding curve of -
synuclein with various concentrations of PCDA (Figure 37B). Their binding 
was monitored by obtaining difference of the intrinsic fluorescence of 
















Figure 37. Specific molecular interaction of 10,12-pentacosadiynoic acid 
(PCDA) for -synuclein leading to facilitated amyloid fibril formation. (A) Self-
oligomerization of -synuclein (35 M) induced by PCDA at various concentrations 
was revealed as a ladder formation on a silver-stained 10-20% Tricine SDS-PAGE 
gel following the EEDQ-mediated crosslinking step. (B) Difference in the tyrosine 
intrinsic fluorescence of -synuclein obtained in the absence (I0) and presence (Ii) of 
various concentrations of PCDA. Double reciprocal plot of the saturation curve 
between 1/(I0-Ii) and 1/[PCDA] (inset). (C) The fibrillation of -synuclein (35 M) in 
the presence of PCDA at various concentrations was monitored by measuring 
solution turbidity at 405 nm. The resulting fibrils of -synuclein obtained with PCDA 
(0.1 mM) after 100 hours of incubation are shown in TEM image (inset). Scale bar, 
200 nm. (D) TEM images of amyloid fibrils (AF) and PCDA-containing amyloid fibrils 
(AF-PCDA). Scale bars represent 200 nm. These fibrils were collected after 
incubating -synuclein (35 M) in the absence (a) and presence (b) of PCDA (0.1 





double-reciprocal plot of the hyperbolic saturation curve yielded Kd of 0.29 
mM from the x-intercept (Figure 37B, inset). This half-saturating PCDA 
concentration was relevant to the concentration dependence of the ladder 
formation in Figure 38A. Then, PCDA effect on the -synuclein fibrillation 
was examined with protein aggregation kinetics by monitoring solution 
turbidity at 405 nm after correcting the turbidity with that of PCDA alone 
(Figure 37C). Thioflavin-T binding fluorescence which has routinely been 
used to monitor the amyloid fibril formation could not be employed here 
because PCDA interferes with the light emission. According to results from 
thioflavin-T binding fluorescence and bicinchoninic acid-based quantitation 
of the protein remaining in the supernatant following precipitation of the 
fibrils, -synuclein alone at 35 M has been shown to effectively transformed 
into amyloid fibrils during more than 100 hours of shaking incubation at 
37°C (Figure 38). The fibrillar end-products were observed with transmission 
electron microscope (TEM) (Figure 38, inset) although the final turbidity was 
not drastically increased (Figure 37C). In the presence of PCDA, the turbidity 
started to increase rapidly without a lag period and reached plateau within 60 
hours of incubation (Figure 37C), which was also assessed with decrease of 
the soluble protein remaining in the supernatant (Figure 39). The final 
turbidities increased as the amount of PCDA increased. The resulting amyloid 
fibrils were revealed with TEM (Figure 37C, inset). Taken together, the -
synuclein fibrillation was dramatically accelerated by PCDA, which supports 
the previous report indicating that polyunsaturated fatty acids enhanced the 










Figure 38. Amyloid fibril formation of -synuclein in the absence of PCDA. 
Fibrillation of -synuclein (35 M) in the absence of PCDA was monitored by using 
thioflavin-T binding fluorescence and the quantitation of -synuclein monomer 
remaining in the supernatant. The final fibrillar structures of -synuclein are shown 







Figure 39. Fibril formations of -synuclein in the absence and presence of 
PCDA. Fibril formation was monitored by measuring both increase of solution 
turbidity at 405 nm and decrease of the amount of -synuclein in the supernatant 
during the incubation. -Synuclein (35 M) was incubated without (A) and with PCDA 




presence of PCDA were compared with each other, the width of -synuclein 
fibrils increased from 10 nm to 16 nm as PCDA was added at 0.1 mM (Figure 
37D). By considering that molecular dimension of a PCDA molecule was 
measured at 3.4 nm [179], the thickening may indicate specific molecular 
association of PCDA into the amyloid fibrils. In order to examine the 
properties of AF and PCDA in the conjugate material, structural properties 
were monitored by using FT-IR spectroscopy and Raman spectroscopy. No 
significant difference was found in the amide I region (1600-1700 cm-1) of 
FT-IR spectra collected with AF and AF/PCDA (Figure 40A). Therefore, it 
is considered that the structure of AF has not been affected by the co-assembly 
with PCDA. On the other hand, however, the 785 nm-laser excited Raman 
spectra indicate that molecular characteristics of PCDA have been affected 
by its incorporation into amyloid fibrils in AF/PCDA conjugates (Figure 40B). 
The spectrum of AF/PCDA shows a slight upshift of the line obtained at 1442 
cm-1 with PCDA alone to 1469 cm-1 and emergence of two new lines at 1531 
cm-1 and 2131 cm-1.  
 
1-2. Chromic and fluorescent properties of AF/PCDA 
In order to examine the chromic and fluorescent properties of AF/PCDA, 
amyloid composites were subjected to UV and heat treatment (Figure 41). 
Upon UV exposure at 254 nm for 10 min, AF/PCDA turned to blue while 
either PCDA alone at 0.1 mM or amyloid fibrils (AF) prepared with 35 M 
-synuclein did not show the color change (Figure 41A). Following heat 











Figure 40. Structural properties of amyloid fibrils (AF) and PCDA in AF/PCDA. 
(A) FT-IR spectra of AF and AF/PCDA. Grey box represents amide I region. (B) 






Figure 41. Chromic and fluorescent properties of AF-PCDA. (A and B) Following 
100 hours of incubation with and without 0.1 mM PCDA, the blue color development 
and the blue-to-red color transition of AF, PCDA monomer, and AF-PCDA upon UV 
exposure at 254 nm for 10 min and subsequent heating for 10 min at 80°C, 
respectively, were shown with a photographic image (A) and absorption spectra (B). 
(C) Fibrillar aggregates of the UV- and heat-treated AF-PCDA were revealed in red 
fluorescence with confocal laser scanning microscope (a) and TEM (b). Scale bars 
represent 10 m.  
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(Figure 41A). UV/Vis absorption spectra of AF/PCDA also indicated the 
chromic property (Figure 41B). For the blue fibrils, the spectrum exhibited 
double maxima at 650 nm and 570 nm, which were shifted to 550 nm and 500 
nm as AF/PCDA experienced the color transition to red. According to these 
results, PCDA molecules are expected to be incorporated into the fibril in a 
well-ordered state and transform into polydiacetylene (PDA), exhibiting the 
colorimetric response of blue-to-red transition. In order to investigate whether 
the chromic property was intrinsic to the fibrils, the red AF/PCDA were 
examined with both confocal laser scanning microscope (CLSM) and TEM 
at the same scale. The red fluorescence of AF/PCDA in CLSM image (Figure 
41C-a) seems to correlate with the fibrillar network in TEM image (Figure 
41C-b), indicating that the colorimetric response of PCDA has occurred in 
association with the amyloid fibrils. All the data therefore suggest that the -
synuclein amyloid fibrils containing PCDA exhibit the chromic and 
fluorescent properties comparable to those elicited by poly-PCDA vesicles 
[180-183]. 
 
1-3. Stimuli-responsive amyloid fibrils  
To assess a potential of AF/PCDA to develop into a robust environment 
sensing agent, their colorimetric responses were explored to changes of 
temperature (Figure 42), pH (Figure 43), and ethanol concentrations (Figure 
44) in comparison with those of conventional poly-PCDA vesicles. With 
temperatures raised, the blue AF/PCDA at 25°C gradually changed their 






Figure 42. Colorimetric response of AF/PCDA to temperature. (A) The color 
transition to red from initial blue was visualized for AF/PCDA and poly-PCDA vesicles 
with variations in temperature. (B) Absorption spectra of AF/PCDA and poly-PCDA 
vesicles with changes of temperature. (C) The colorimetric responses of AF-PCDA 








Figure 43. Colorimetric response of AF/PCDA to pH. (A) The color transition to 
red from initial blue was visualized for AF/PCDA and poly-PCDA vesicles with 
variations in pH. (B) Absorption spectra of AF/PCDA and poly-PCDA vesicles with 
changes of pH. (C) The colorimetric responses of AF-PCDA and poly-PCDA vesicles 







Figure 44. Colorimetric response of AF/PCDA to ethanol. (A) The color transition 
to red from initial blue was visualized for AF/PCDA and poly-PCDA vesicles with 
variations in ethanol concentration. (B) Absorption spectra of AF/PCDA and poly-
PCDA vesicles with changes of ethanol concentration. (C) The colorimetric 
responses of AF-PCDA and poly-PCDA vesicles obtained in % CR were plotted as 




vesicles showed abrupt color change from blue to red at 65°C (Figure 42A). 
To quantify the blue-to-red color transition of AF/PCDA and poly-PCDA 
vesicles, the % colorimetric response (% CR) was calculated by comparing 
the two maximum peaks at 650 nm and 550 nm of the absorption spectra 
representing the blue and red phases, respectively (Figure 42B). The plot of % 
CR as a function of temperature (Figure 42C) showed that % CR of AF/PCDA 
slowly increased from 55°C to 80°C while poly-PCDA vesicles underwent a 
steep change at 60°C and reached plateau above 70°C. The blue-to-red color 
transition has been known to be caused by the increased segmental dynamics 
of PCDA molecules with heat and thus relieving the strain in the conjugated 
backbone of PDA [184, 185]. Therefore, the fact that AF/PCDA were capable 
of detecting temperature change in a wider range than poly-PCDA vesicles 
would be caused by the restricted molecular freedom of PCDA assembled on 
the amyloid fibrils. 
 The pH-responsive color changes of AF/PCDA and poly-PCDA 
vesicles were examined by adding either HCl or NaOH to the initial blue 
phase (Figure 43). While both AF/PCDA and poly-PCDA vesicles did not 
respond to the acidification, the apparent blue-to-red color transition occurred 
at basic pH around 11 for both species (Figure 43A). The pH-% CR plots 
obtained from their absorption spectra (Figure 43B) indicated that both 
AF/PCDA and poly-PCDA vesicles responded similarly (Figure 43C). 
Therefore, AF/PCDA system could be employed to detect pH variation on the 
basic range like poly-PCDA vesicles. AF/PCDA also exhibited the color 
transition with ethanol (Figure 44). In the case of AF/PCDA, the blue-to-red 
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color transition did not appear until 50% ethanol and started to occur slowly 
from 60% to 80% ethanol. The blue poly-PCDA vesicles, however, abruptly 
changed their color to red at 60% ethanol (Figure 44A). The ethanol-% CR 
plots indicated that AF/PCDA increased % CR linearly from 60% to 90% 
ethanol while poly-PCDA vesicles raised % CR rather quickly between 60% 
and 70% (Figure 44C). AF/PCDA could be considered to be adequate to 
monitor the solvent in a wider range. Taken together, AF/PCDA have been 
demonstrated to be more effective sensing agent exhibiting the colorimetric 
responses toward temperature, pH, and ethanol than poly-PCDA vesicles by 
widening the detection range which may result from structural restriction of 
the PCDA molecules polymerized on the amyloid fibrils. 
 
1-4. Enhanced stability of AF/PCDA against mechanical stress 
Owing to structural instability of poly-PCDA vesicles, their use as 
environment sensing agent could have been limited. In contrast, AF/PCDA 
could be versatile for their use as a sensing material because not only the 
PCDA molecules have been shown to be well-maintained upon exposure to 
the external stimuli but also amyloid fibrils are recognized to be one of the 
mechanically strongest biological materials available in nature [164]. In 
addition, the specific incorporation of PCDA molecules into amyloid fibrils 
and their topochemical photopolymerization into PDA on the fibrils would 
further fortify the resulting AF/PCDA. Therefore, mechanical stability of AF-
PCDA was tested with sonication and compared with that of poly-PCDA 
vesicles and AF alone (Figure 45). The structural disruption and color 
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transitions of AF/PCDA and poly-PCDA vesicles were monitored after they 
were repeatedly treated with increasing number of the on/off cycle of 
sonication (10 sec/10 sec) (Figure 45A). As expected, AF/PCDA were 
demonstrated to be mechanically stable because not only their initial blue and 
red colors remained undisrupted even after 80 cycles of sonication (Figure 
45A-a), but also the blue-to-red colorimetric transition was not affected even 
for the blue AF/PCDA pre-treated with 80 cycles of sonication (Figure 45A-
c). For the poly-PCDA vesicles, however, their initial blue and red colors 
disappeared instantly right after 20 cycles of sonication, indicating structural 
vulnerability of the vesicles (Figure 45A-b). As a result, therefore, their 
colorimetric response was lost as the vesicular intactness was affected by 
sonication. The absorption spectra of AF/PCDA and poly-PCDA vesicles also 
indicated that the absorbance maxima of AF/PCDA were not affected by 
sonication (Figure 45B-a) while those of poly-PCDA vesicles drastically 
decreased only with 20 cycles of sonication (Figure 45B-b). The results 
obviously illustrated that poly-PCDA produced on the amyloid fibrils was 
mechanically tolerant toward the mechanical stress compared to poly-PCDA 
of the vesicles. Additionally, the fortifying effect of poly-PCDA to the fibrils 
was evaluated with TEM analyses of AF/PCDA and AF without PCDA 
incorporated following the sonication (Figure 46). AF alone were readily 
fragmented into short pieces with an average length of 200 nm after 20 cycles 
of sonication and completely broken down to the smaller pieces of 30 nm in 
average after 80 cycles. AF/PCDA, however, did not fragment into separate 







Figure 45. Enhanced stability of PCDA assembly in AF/PCDA against 
sonication-mediated mechanical stress. (A) The blue and red colors of AF/PCDA 
(i) and poly-PCDA vesicles (ii) obtained in the absence or presence of heat-treatment 
(80°C for 10 min) were subjected to the numbers of sonication indicated. The blue-
to-red color transition of the blue AF/PCDA obtained after 80 cycles of sonication 
was observed with heat-treatment at 80°C for 10 min (iii). (B) Absorption spectra of 
AF/PCDA (i) and poly-PCDA vesicles (ii) obtained with and without the heat-
treatment were shown after being subjected to the numbers of sonication indicated 
(black for 0 cycle, blue for 20 cycles, red for 40 cycles, green for 60 cycle, and yellow 












Figure 46. Enhanced stability of amyloid fibrils by interacting with PCDA. TEM 
images of AF and AF/PCDA obtained with and without the heat-treatment are shown 
after those fibrils were subjected to sonication with the number of cycles indicated. 





initial fibrils of AF/PCDA turned into the fibrillar networks with either 
thicker fibrils or rather smaller version of the fibrils as the sonication was 
repeated. Therefore, the incorporation of PCDA into AF and subsequent PDA 
formation yielded a colorimetric sensing material with mechanical strength 
far beyond that of conventional poly-PCDA vesicles by fortifying the fibrils 
with the on-site photopolymerization into PDA.  
 
Herein, novel functional amyloid fibrils with chromic and fluorescent 
properties have been shown to be successfully produced by introducing 
PCDA into the self-assembly process of -synuclein (Scheme 6). By taking 
advantage of the structural regularity of amyloid fibrils and the specific 
molecular interaction of a fatty acid analog of PCDA with -synuclein as 
assessed with the crosslinking experiment with EEDQ and the accelerated 
fibrillation, the robust and effective PDA-based sensing material has been 
developed on the AF of -synuclein. The resulting AF/PCDA exhibited the 
colorimetric response of blue-to-red transition toward the changes of 
temperature, pH, and ethanol concentrations in wider ranges than those 
observed with poly-PCDA vesicles, which could be due to restricted 
molecular freedom of PCDA polymerized on AF. In addition, AF/PCDA 
were more mechanically stable than either AF alone or poly-PCDA vesicles 
as evaluated with their structural tolerance against the mechanical stress 
provided by sonication. Therefore, simplicity of AF/PCDA production, 
improved sensing capability, and the mechanical stability could allow this 















areas of sensor development by replacing the current vesicular type active 
material or fabricating the fibril-based two- or three-dimensional 
suprastructures such as films or hydrogels. 
 
2. Litmus-type biosensor based on the PCDA-containing amyloid 
fibrils  
 
2-1. Colorimetric transition of the PCDA-containing amyloid 
fibrils of -synuclein layered on paper 
The amyloid fibril and PCDA composites (AF/PCDA) prepared via co-
incubation between -synuclein and PCDA for 70 hours at 37°C were spotted 
onto Whatman cellulose filter paper, air-dried for 2 hours, and exposed to UV 
light at 254 nm for 1 min. As confirmed in solution, the AF/PCDA spotted on 
paper turned to blue color upon UV exposure and subsequently converted to 
red with heat-treatment at 80°C (Figure 47A). The PCDA monomers on paper 
did not respond to UV light, indicating that PCDA molecules could not align 
to form the color developing polymers by themselves on the paper. In the case 
of the PCDA vesicles, they became aggregated on paper, which left a few 
blue dots within the spot following UV exposure. Even in the presence of -
synuclein monomers, the PCDA molecules still did not turn to blue with UV, 
which suggests that amyloid fibrils are crucial to accommodate PCDA into 
an ordered alignment for the photopolymerization.  
 To prove whether amyloid fibrils could serve an optimal template for 

















Figure 47. Colorimetric litmus-type sensor developed with -synuclein 
amyloid fibrils and PCDA. (A) Colorimetric responses of the amyloid fibril and 
PCDA composites (AF/PCDA) in solution and on paper to UV exposure and heat 
treatment. AF/PCDA were prepared via coincubation of -synuclein (1 mg/ml) and 
PCDA (1 mM) for 70 hours at 37°C. PCDA monomers, PCDA vesicles, and PCDA 
monomers with monomeric -synuclein (Syn/PCDA) were spotted on paper for 
negative controls. (B) Colorimetric responses of the mixture of pre-made amyloids 
fibrils (AF) and PCDA (AF+PCDA) on paper. AF and PCDA were either separately 
spotted on paper in succession (upper row) or in the form of AF+PCDA obtained 
after 15 min of incubation between AF and PCDA (lower row). Both papers were 





based litmus-type sensor, the pre-made amyloid fibrils (AFs) of -synuclein 
were employed to examine their colorimetric response on paper in the 
presence of PCDA (Figure 47B). Whereas two successive spotting of the pre-
made AFs and PCDA with air-dry for 2 hours after each spotting did not 
exhibit blue color upon the UV exposure, a mixture of the pre-made AFs and 
PCDA (AF+PCDA) incubated for 15 min under dark prior to spotting onto 
Whatman paper gave rise to blue color with UV and transition to red with the 
heat-treatment at 80°C for 5 min. These data indicate that the PCDA 
molecules may prefer the cellulose paper surface to the AFs pre-spotted on 
the paper. In solution, however, the PDA monomers apparently require AFs 
to be aligned on the templates. After all, two types of PCDA-based litmus-
type sensing materials have been prepared with AFs of -synuclein - 
AF/PCDA and AF+PCDA - .  
 
2-2. Paper-based colorimetric thermal responses of AF/PCDA and 
AF+PCDA and their applications 
To evaluate temperature sensing property of AF/PCDA and AF+PCDA 
spotted on paper with UV exposure, the blue-to-red color transition was 
examined for the spots after 5 min of incubation at various temperatures from 
25°C to 90°C (Figure 48A). For the AF/PCDA, the color transition along 
with the fluorescence enhancement gradually occurred at the higher 
temperature range between 60°C and 90°C where the red color became 
apparent from 80°C. The AF+PCDA, on the other hand, exhibited their 










Figure 48. Thermal response of the litmus-type sensors. (A) Colorimetric 
transition and fluorescence enhancement of AF/PCDA and AF+PCDA on paper at 
various temperatures. (B) The fluorescence intensities of the heat-treated paper 
sensors were plotted with the temperatures by analyzing their fluorescence images 





red appeared from 55°C. Difference in their color transition temperatures of 
AF/PCDA and AF+PCDA was clearly demonstrated with a plot of the 
fluorescence intensities of the spots obtained via digital image analysis 
following 5 min incubation at various temperatures (Figure 48B). Since 
AF/PCDA and AF+PCDA have mutually exclusive temperature ranges for 
the colorimetric response, the litmus-type thermal sensors employing either 
material could cover a wide range of temperature and act complementary to 
each other.  
 In order to confirm whether the litmus-type sensor is capable of 
following temperature change in real-time, the paper sensor prepared with 
AF+PCDA was continuously heated on a hot plate. The blue spot gradually 
changed its color to red as the temperature increased from 25°C to 60°C 
(Figure 49A). The red color did not convert back to blue when the temperature 
decreased to room temperature. This irreversible thermal sensing property 
detecting only ascending temperature change would be useful for the paper 
sensor to monitor thermal history of materials by assessing a maximum 
temperature the materials have experienced. Another use of the litmus-type 
thermal sensor is to locate an exact heated spot adjacent to unaffected areas 
as demonstrated with the blue AF+PCDA-containing paper which converted 
to red in a shape of musical sharp sign after a local heating provided to the 
copper tapes attached underneath the blue paper in the same shape (Figure 
49B). Intriguingly, the entire paper sensor turned to dark brown upon 
additional UV exposure with complete disappearance of the red sharp sign 








Figure 49. Applications of the AF+PCDA litmus-type sensors in temperature 
detection. (A) Monitoring temperature change of a hot plate in real-time with the 
litmus-type sensor of AF+PCDA. (B) Monitoring the local heating of the AF+PCDA 
litmus type sensor with the copper tapes aligned and heated in a shape of musical 
sharp sign; and reversible thermal sensing property of the paper sensor observed 
with additional UV and heat treatments. (C) Reversibility of the thermochromic 
sensing property of AF+PCDA on paper assessed with variations in the duration of 






lasted at least three to four times. In order to clarify whether this reversibility 
was due to either the excess PCDA monomers on AFs not photopolymerized 
with a prior UV exposure or a large-scale conformational change of the 
activated poly-PCDA network, the duration of initial UV exposure was varied 
for the AF+PCDA paper sensor (Figure 49C). The red spot derived from the 
blue AF+PCDA obtained with 1 min of the initial UV exposure turned to dark 
brown upon an additional UV exposure for 20 min, which again showed the 
color transition to red with heating for 1 min at 80°C. Upon another 
subsequent UV exposure, the red became blueish. The first red-to-purple 
transition, however, became less apparent as the duration of initial UV 
exposure increased to obtain the blue spot for AF+PCDA. This result suggests 
that the reversible heat sensing property of AF+PCDA on paper could be 
caused by the presence of unreacted excess PCDA monomers yet to be 
aligned within the templates. Taken together, the litmus-type sensors 
developed with amyloid fibrils of -synuclein in the presence of PCDA have 
been demonstrated to detect not only thermal history of materials in general 
but also their heated local spots in a reversible manner.  
 
2-3. Interaction between PCDA and amyloid fibrils within 
AF/PCDA and AF+PCDA 
Since the simple mixture between pre-made AFs and PCDA was 
demonstrated to detect the lower temperatures, the molecular interaction of 
PCDA for amyloid fibrils would be distinctive in between AF/PCDA and 
AF+PCDA. Sonication was employed to test tightness of PCDA binding to 
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the fibrils. Following repetitive sonications up to 3 times with 2 sec of 
sonication for each, both AF/PCDA and AF+PCDA were separately 
precipitated to remove unbound or unleashed PCDA. After resuspending the 
precipitates, they were spotted onto the paper and subjected to UV exposure 
at 254 nm for 1 min (Figure 50A). The resulting blue color development 
indicated that AF+PCDA had lost most of its ability to be photopolymerized 
right after the first sonication. Two consecutive sonications deprived 
AF+PCDA of the blue color development on paper. AF/PCDA, on the other 
hand, turned to blue even after three times of sonication. These data suggest 
that PCDA molecules have bound to AF less tightly within AF+PCDA than 
AF/PCDA, which could be responsible for the difference in their colorimetric 
response toward temperatures. In other words, the paper sensor prepared with 
AF/PCDA has required the higher temperatures to exhibit the blue-to-red 
transition since the PCDA molecules appear to exist in a more tightly bound 
and, thereby, restricted state within AF which would hamper the 
conformational mobility of poly-PCDA for the red color transition.  
 Distinctive mode of interaction between PCDA and AF in AF/PCDA 
and AF+PCDA was investigated with Raman spectroscopy (Figure 50B). For 
vesicular poly-PCDA, three primary peaks were observed at 1442 cm-1, 1794 
cm-1, and 2092 cm-1 in the spectrum, which correspond to alkene, C=O, and 
alkyne stretching mode of poly-PCDA, respectively. Two of the primary 
peaks of poly-PCDA shifted to 1458 cm-1 and 2081 cm-1 in AF/PCDA with a 
new small peak emerged at 1520 cm-1. The peak of poly-PCDA at 1794 cm-1 





Figure 50. Distinctive interactions of PCDA molecules with the amyloid fibrils 
in either AF/PCDA or AF+PCDA. (A) Analysis of the tightness of PCDA binding to 
amyloid fibrils by observing the blue color development with UV exposure following 
a number of repetitive sonications for 2 sec each as indicated on the top of panels. 





the alkene peak appeared at 1455 cm-1 with an additional peak at 1515 cm-1. 
In the high frequency Raman shift range, the alkyne peak appeared split into 
two at 2092 cm-1 and 2131 cm-1. Although those peaks are not designated with 
specific chemical bonds, variations in the Raman scattering peaks of PCDA 
in the complexes clearly indicate unique environment and special molecular 
arrangement of PCDA in AF/PCDA and AF+PCDA. Taken together, it is 
pertinent to consider that the difference in thermal sensing property between 
AF/PCDA and AF+PCDA could be attributed to distinctive molecular 
alignment of PCDA and its molecular freedom in the complexes. 
 
2-4. Colorimetric response of the litmus-type sensor to organic 
solvents 
Difference in their sensing ability of the litmus-type sensors prepared with 
either AF/PCDA or AF+PCDA was also examined with various volatile 
organic solvents (Figure 51). The AF/PCDA sensors instantly changed their 
colors from blue to purple when they were dipped in the solvents as shown 
in Figure 51A, but the color transitions were not observed with the solvent 
vapors even after 1 hour of exposure. The blue paper sensors made with 
AF+PCDA, on the other hand, exhibited various colors from purple to 
discrete red as they contacted the solvents directly. When they exhibited the 
color transition especially in chloroform, methylene chloride, benzene, 
toluene, and xylene, their resulting red colors became more vivid when 
compared with the purple colors of the AF/PCDA sensors. Intriguingly, the 










Figure 51. Colorimetric and fluorescent responses of the litmus-type sensors 
with AF/PCDA and AF+PCDA to various organic solvents. (A) Solvatochromic 
properties of the AF/PCDA and AF+PCDA on paper upon the exposure to solvents 
and their vapors. (B) Time-resolved colorimetric transition and fluorescence 
enhancement of the AF+PCDA paper sensors with the exposure to the solvent 





vapors of solvents such as acetone, chloroform, methylene chloride, benzene, 
toluene, and xylene within 5 min of exposure (Figure 51A). The less tight 
binding and thus high mobility of poly-PCDA on AFs in AF+PCDA would 
be responsible for its improved sensitivity toward the solvent vapors from that 
of the AF/PCDA sensors as seen in the thermal sensing property of 
AF+PCDA detecting the lower temperatures. Furthermore, the vapor-induced 
color change of the AF+PCDA sensors exhibited a gradual shift in color from 
blue to red emitting fluorescence as the vapor exposure time increased 
especially for ethanol, acetone, and xylene (Figure 51B). This time-dependent 
vapor detection property could be used to monitor the duration of toxic vapor 
exposures.  
 
In this study, the litmus-type sensors have been made with -synuclein 
amyloid fibrils and 10, 12-pentacosadiynoic acid (PCDA). The PCDA 
molecules were fabricated into the amyloid fibrils via either coincubation 
with monomeric -synuclein (AF/PCDA) or mixing with its pre-made fibrils 
(AF+PCDA). The PCDA molecules aligned on amyloid fibrils were 
photopolymerized to exhibit blue color with UV exposure and respond to 
external stimuli such as temperature and solvents by exhibiting the blue-to-
red color transition on paper. The paper sensors prepared with AF/PCDA and 
AF+PCDA showed different sensing properties toward the stimuli possibly 
due to molecular freedom of the bound PCDA. The litmus-type sensor with 
AF+PCDA shown to contain the less tightly bound PCDA was able to detect 
the lower temperatures and the vapors of certain organic solvents within a 
140 
 
short period of exposure. Furthermore, the AF+PCDA sensor could monitor 
the temperature change of materials in real-time and locate the heated spots 
by exhibiting the blue-to-red color transition. Therefore, the litmus-type 
sensors conveniently manufactured by placing the nanocomposites of 
amyloid fibrils and polydiacetylene onto a filter paper can be employed to 
monitor thermal history of materials in general and organic compounds 




This study has shown that amyloid fibrils of -synuclein can be utilized as 
promising biomaterials via playing a role as a powerful template for assembly 
of 10,12-pentacosadiynoic acid (PCDA). 
(1) -Synuclein specifically interacts with PCDA which has a carboxylic 
group with along aliphatic chain like fatty acids in nature.  
(2) PCDA molecules can be aligned on amyloid fibrils (AF) via either 
coincubation with monomeric -synuclein (AF/PCDA) or mixing with its 
pre-made fibrils (AF+PCDA). 
(3) PCDA molecules aligned on AF were photopolymerized with UV and 
responded to external stimuli such as temperature, pH and solvents, 
exhibiting blue-to-red color transition. 
(4) PCDA molecules assembled with AF template remained stable not only 
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국문 초록  
 
 아밀로이드성 단백질인 알파-시뉴클린(-Synuclein, S)은 파
킨슨씨병 환자에게서 공통적으로 관찰되는 루이소체(Lewy Bodies)
의 주요 구성성분이다. S이 아밀로이드로 조립화되는 과정에는 올
리고머(Oligomer)가 중간체로 관찰되며 이들은 단위조립(Unit 
Assembly) 과정을 통해 다양한 물리화학적 특성을 나타내는 섬유
상 구조체로 조립화되어 아밀로이드 다형성(Polymorphism)을 나타
낸다. 더 나아가 S 올리고머는 지질막 표면상에서 단위조립화를 
나타냄으로써 방사성 아밀로이드 구조체를 형성하고, 그 결과 지
질막 구조를 붕괴시킴이 확인되었다. 따라서, S 올리고머의 지질
막상 단위조립화 특성은 S에 의한 세포퇴화의 분자적 원인으로 
간주되고 있다. 
 이에 본 연구에서는 S 상호작용성 분자들을 탐색하여 올
리고머에 의한 세포독성을 제어하고자 하였다. 먼저 S과 효소간 
상호작용을 통해 효소의 활성이 향상되고 아밀로이드 형성이 촉진
됨을 확인할 수 있었다. 반딧불 루시페라아제(LUC)과 글루타티온 
과산화효소(GPX-1)은 S과 결합하여 각각 8.1 M, 17.3 nM의 Kd 값
을 나타낸다. 이들은 새로운 지지체(Template)를 제공함으로써 S 
섬유화를 촉진시키고 섬유 다형성을 유도한다. 형광염료결합 분석
법, 투과전자현미경, 푸리에 변환 적외선분광법을 이용하여 효소에 
의해 유도된 아밀로이드 섬유의 형태적 차이를 관찰하였다. LUC에 
의해 유도된 아밀로이드 섬유의 형태적 특징은 핵 의존성 섬유화 
과정(Nucleation-Dependent Fibrillation)을 통해 다음 세대로전달되었
다. 따라서 씨앗(Seed) 제어는 아밀로이드 섬유의 생화학적 특성변
화를 유도하기 위한 효과적인 방법이라 할 수 있다. 또한, LUC에 
의한 아밀로이드 섬유의 다형성 결과로부터 세포 내 다양한 분자
들 또한 아밀로이드 섬유를 다양하게 만들고 이는 세포 내에서 다
양한 활성을 갖도록 자가증식(Self-Propagation)할 것이라 예상할 수 
있다 과 GPX-1간 상호작용의 결과물인 섬유 구조체를 금 나노 
입자가 결합된 항체로 GPX-1을 표시하고 전자현미경으로 관찰하
면, 섬유 구조체 안에 갇혀 있는 GPX-1을 확인할 수 있다. 흥미롭
게도 이 GPX-1는 섬유 구조체 안에 잠복상태(Latent Form)로 갇혀 
있다가 그물에서 빠져나오며 활성이 완전히 회복되었다. 따라서 
과 그 아밀로이드 섬유는 GPX-1 자극제(Activator)와 활성효소 
저장소의 역할을 함으로써 산화적 스트레스로부터 세포를 보호하
는 새로운 기능을 보여준다. 
 몇몇 폴리페놀은 S 올리고머가 세포막과 세포생존율에 끼
치는 영향을 제어하는 것으로 관찰되었다. 우선, -Sheet 구조가 없
고, 반복적인 막 투과 과정을 통해 Curly Amyloid Fibril (CAF)로 조
립되며 라이포솜 표면에서 즉각적으로 Radiating Amyloid Fibril (RAF)
를 형성하는 특정 올리고머를 활성 올리고머(Active Oligomer)라 정
의하였다 의 타이로신 내재 형광(Tyrosine Intrinsic Fluorescence) 
변화를 측정함으로써 단백질과 페놀화합물인 레스베라트롤
(Resveratrol, RSV), 커큐민(Curcumin, CUR), 녹차 카테킨((-)-
Epigallocatechin Gallate, EGCG)이 결합하는 것을 확인하였다. CBB로 
염색한 SDS-PAGE와 CD 분광법을 통해 이들 페놀화합물이 S 섬
유화에 영향을 주어 다른 특성을 갖는 올리고머(Compact Oligomer) 
형성을 유도하거나 -Sheet을 다량 함유하는 아밀로이드 섬유 형성
을 촉진시키는 것을 관찰하였다. 특히 녹차 폴리페놀인 EGCG의 
경우, 올리고머를 빠르게 아밀로이드로 조립시켜 올리고머가 더 
이상 지질막 및 세포에 영향을 주지 못하도록 했다. 따라서 EGCG
를 포함한 S 상호작용성 분자들은 올리고머에 의한 세포독성을 
제어할 수 있으며, 이는 파킨슨씨병의 치료물질로 활용될 수 있음
을 보여준다. 
 규칙적인 구조와 높은 물리적 강도가 특성인 아밀로이드 
섬유는 재료과학 측면에서 응용 가능성이 높은 생물재료라 평가된
다. 이에 본 연구에서는 S 아밀로이드 섬유를 지지체로 하여 
Diacetylene의 일종인 10,12-Pentacosadiynoic Acid (PCDA) 기반 비색
성 센서를 개발하였다. PCDA는 S의 올리고머 형성을 촉진 시킬 
뿐만 아니라 섬유화 과정에도 영향을 주어 섬유화를 촉진시키고 
그 결과 두께가 증가한 섬유 구조체를 형성한다. UV를 조사하면, 
PCDA를 포함하는 아밀로이드 섬유(AF/PCDA)는 파란색을 띠고 열
을 가하면 빨간색으로 변한다. 이와 같은 파랑-빨강 색 전이는 pH
와 에탄올에 노출되었을 때에도 관찰된다. 구조가 안정한 
AF/PCDA는 PCDA Vesicle과 달리 반복적인 음파처리(Sonication)에
도 색을 잘 유지하였다. 따라서 AF/PCDA는 강도가 향상된 PDA 
기반의 새로운 비색성 센서이며, 다양한 분야에서 활용 가능할 것
이다. 더 나아가 아밀로이드 섬유과 PCDA를 이용하여 온도와 유
기용매를 감지할 수 있는 리트머스 형태의 센서도 개발하였다. 
PCDA 분자들은 S 모노머와 함께 반응하여 섬유구조체를 형성하
거나(AF/PCDA), 이미 만들어진 아밀로이드 섬유와 반응하여
(AF+PCDA) 아밀로이드 섬유에 결합되고, 이들은 종이 위에서 UV
에 의해 고분자화 되어 파란색을 띤다. AF/PCDA와 AF+PCDA로 제
작된 종이 센서는 온도와 유기용매 감지에 대해 서로 다른 민감도
를 보인다. 아밀로이드 섬유에 약하게 결합된 PCDA는 분자 자유
도가 높아 감지 능력에 영향을 준다. 또한, AF+PCDA 센서는 온도 
변화를 성공적으로 감지할 수 있어 물질의 열 이력(Thermal History)
를 추적하는데 활용될 수 있다. 이와 같은 결과로부터 S 아밀로
이드 섬유는 PCDA의 지지체로 적합하여 온도와 유기용매를 감지
할 수 있는 리트머스 형태의 센서로 개발될 수 있다.  
 
주요어 
알파-시뉴클린; 활성 올리고머; 단위 조립; 알파-시뉴클린 상호작용
성 분자; 폴리다이아세틸렌; 아밀로이드 기반 센서 
